March, 2015
Curriculum Vitae
Fred Carron Tenover, Ph.D. (D) A.B.M.M., (F) A.A.M., (F) I.D.S.A.
Personal Data
Birth:
Citizenship:
Marital Status:
Business Address:
Education
1972-76
1976-80
1980-82
1982
Positions
2013-Present
2010-2013
2008-2010
2009-present
1994-Present
2008
2007-2008
2000-2007
1998-2008
1997-2008
1990-2000
1996-2006
1991-1996
1990-1991
1989-1990
1988-1990
1982-1988
1987-1990
1982-1987
1982-1985
October 28, 1954, Kalamazoo, Michigan
U.S.A.
Married, one child
Cepheid
904 Caribbean Drive
Sunnyvale, CA 94089
B.S., University of Dayton, Dayton, Ohio. Biology and Chemistry
M.S., Ph.D., University of Rochester, Rochester, N.Y. Microbiology (Awarded February 1981)
Postdoctoral Fellow, Clinical Microbiology and Public Health, University of Washington, Seattle
Chief Fellow, Department of Laboratory Medicine University of Washington, Seattle
Vice President, Scientific Affairs, Cepheid
Executive Director, Scientific Affairs, Cepheid
Senior Director, Scientific Affairs, Cepheid
Consulting Professor, Department of Pathology, Stanford University, Stanford, CA
Adjunct Professor, Department of Epidemiology, Emory University School of Public Health, Atlanta, GA
Distinguished Consultant, Centers for Disease Control and Prevention
Director, Office of Antimicrobial Resistance, Centers for Disease Control and Prevention, Atlanta, GA
Associate Director for Laboratory Science, Division of Healthcare Quality Promotion, Centers for Disease
Control and Prevention, Atlanta, GA
Senior Biomedical Research Service, Centers for Disease Control and Prevention Atlanta, GA
Director, Centers for Disease Control and Prevention/ World Health Organization Collaborating Center for
Global Antimicrobial Resistance Monitoring, Atlanta, GA
Chief, Nosocomial Pathogens Laboratory Branch, Centers for Disease Control and Prevention, Atlanta, GA
Adjunct Professor, Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA
Adjunct Associate Professor, Department of Pathology and Laboratory Medicine, Emory University,
Atlanta, GA
Chief, Antimicrobics Investigation Branch, Centers for Disease Control, Atlanta, GA
Chief, Molecular Biology Section, Clinical Laboratory, VA Medical Center, Seattle, WA
Acting Chief, Microbiology Section, Clinical Laboratory, VA Medical Center, Seattle, WA
Associate Chief, Microbiology Section, Clinical Laboratory, VA Medical Center, Seattle, WA
Associate Professor, Department of Laboratory Medicine, Adjunct Associate Professor, Department of
Microbiology, School of Medicine, University of Washington, Seattle, WA.
Assistant Professor, Department of Laboratory Medicine, Adjunct Assistant Professor, Department of
Microbiology School of Medicine, University of Washington, Seattle, WA.
Consultant, U.S. Agency for International Development through Boston University to Suez Canal
University, Faculty of Medicine, Ismailia, Egypt
Certification
1988-present
Diplomate: American Board of Medical Microbiology
Grants
2010-2011
National Institutes of Health, “Diagnostics for the Rapid Treatment of Multidrug-Resistance in Healthcare”
1
1988-1991
1985-1988
1984-1985
FC Tenover, Co-Principal Investigator, $2,148,746
Veterans Administration Merit Review "Campylobacter Genetics" FC Tenover, Principal Investigator,
$181,000
Veterans Administration Merit Review "Campylobacter Genetics" FC Tenover, Principal Investigator,
$160,000
Veterans Administration Research Advisory Group "Campylobacter Auxotyping", FC Tenover, Principal,
Investigator, $25,000
Fellows & Trainees
1988-1989
Pere Coll, M.D., Ph.D. Currently; Professor, Microbiology Autonomous University of Barcelona, Spain
1988-1990
Caroline A. Ryan, M.D. Currently; AIDS Education Project, University of Washington, Seattle.
1990-1994
Ming-Bo Huang , M.D. Visiting Scientist, Guangxi University, People's Republic of China. Currently:
Research Associate, Morehouse School of Medicine, Atlanta, GA
1991-1994
Bente Olsvik, D.D.S. - Visiting Scientist, Norway, Currently: Research Associate, Tromso University,
Norway
1993-1994
Ørjan Olsvik, Ph.D. - Visiting Scientist, Norway Currently: Chairman: Department of Medical
Microbiology, Tromso University, Norway
1993-1994
Helio Caiaffa-Filho, Ph.D. - Visiting Scientist, Brazil. Currently, Clinical Microbiology Laboratory
Director, Sao Paulo, Brazil
1993-1994
Corinne Jay, Ph.D. - Visiting Scientist, Lyon, France. Currently, Section Leader, bioMérieux, Lyon, France
1994-1996
James Raynor, Ph.D. - ASM Postdoctoral Fellow, Currently Faculty member Fayetteville State University,
North Carolina.
1995-1997
Linda Weigel, Ph.D. - ASM Postdoctoral Fellow. Currently, Microbiologist, Centers for Disease Control
and Prevention
1995-1996
Sachiko Satake, Ph.D. - Visiting Scientist, Currently, Associate Professor, Gunma University, Japan
1996-1997
Erika D’Agata, M.D. - CDC/NEDMC Fellowship Program. Currently, Faculty member, Vanderbilt
University, Tennessee.
1997
Federico Nicola, M.D. - Visiting Scientist, Argentina. Currently, Fellow Laboratory Medicine, Rosario
University, Argentina
1997
Belinda Ostrowski, M.D. - Visiting Scientist, CDC/NEDMC Fellowship Program, Currently, Hospital
Epidemiologist University of Virginia Hospital
1997-1998
Deione Reed, Ph.D. - ASM Postdoctoral Fellow
1998
Clare Gentry, M.S. - CDC Summer Fellowship Program. Currently, Medical Resident University of Texas
School of Medicine
1998-2001
Hesna Yigit, Ph.D. - ASM Postdoctoral Fellow
1998-1999
Jaana Vupio-Varkila, M.D., Ph.D. - CDC-International Emerging Infectious Diseases Fellow. Currently,
Director, Bacteriology, KTL, Finland
1999-2000
Alaeddin Abu-Zant, M.S. - CDC-International Emerging Infectious Diseases Fellow
2000
Wee-Gyo Lee, M.D., Ph.D. - Visiting Scientist, Seoul, Korea. Currently, Assistant Professor, Dept. of
Clinical Pathology, Ajou University
2000
Keith Kaye, M.D. Currently, Hospital Epidemiologist, Duke University Medical Center
2000-2001
Antonio Oliver, Ph.D. Visiting Scientist, Spain. Currently, Professor, University of Majorca, Spain
2002
Mitchell Schwaber, M.D., Visiting Scientist, CDC/NEDMC Fellowship Program, Currently, Faculty
member, University of Tel-Aviv
2002
Stephen Weber, M.D. Visiting Scientist, CDC/NEDMC Fellowship Program, Currently, Faculty member,
University of Chicago.
2007
Evan Tingerington, B.S., M.P.H. Served as Field Advisor for MPH Studies, Currently, Physician
2007
Samantha Eells, B.S., M.P.H. Served as Field Advisor for MPH Studies, Currently Assistant Professor,
UCLA School of Medicine
2008
Jared Fisher, B.S., M.P.H. Served as Field Advisor for MPH Studies.
2012
Nicole Tarlton, B.S., M.S. Molecular biology intern at Cepheid. Currently in Ph.D. program UC Berkeley
2
Honors, Awards, Invited Positions
2014
External reviewer, Networks of Centres of Excellence, Canada
2013
American Society for Microbiology, Division L Lecturer, General Meeting, Denver, CO
2011
Clinical Laboratory and Standards Institute Service Award for Leadership and Service as Co-Chair of X07R—Surveillance for Methicillin-Resistant Staphylococcus aureus: Principles, Practices, and Challenges; A
Report.
2008
Centers for Disease Control and Prevention Award for Outstanding Performance as a Senior Biomedical
Scientist.
2006
National Center for Infectious Diseases Recognition Award for Public Health Research and Service
2005
Food and Drug Administration’s Group Recognition Award for Outstanding Service: VancomycinResistant Staphylococcus Collaboration Group
2005
Invited Faculty, Antimicrobial Resistance Prevention Initiative; American Society for Microbiology and
Society for Healthcare Epidemiology of America
2004
James H. Nakano Citation (outstanding scientific publication), National Center for Infectious Diseases,
Centers for Disease Control and Prevention
2003
CDC Communications Roundtable Award. Outstanding Electronic Media Program. “Antimicrobial
Susceptibility Testing; A Self-Study Course.” CD-ROM
2003
James H. Nakano Citation (outstanding scientific publication), National Center for Infectious Diseases,
Centers for Disease Control and Prevention.
2003
President, Congress on Proficiency Testing, Pan American Health Organization, Santiago, Chile
2002
Health and Human Services Secretary’s Award for Distinguished Service; Anthrax Investigation
Emergency Response Team
2002
Outstanding Alumni Award: Msgr. John R. Hackett High School, Kalamazoo, MI
2002
James H. Nakano Citation (outstanding scientific publication), National Center for Infectious Diseases,
Centers for Disease Control and Prevention.
2000
BD Biosciences Award for outstanding contributions to Clinical Microbiology. Awarded by the American
Society for Microbiology.
2000
James H. Nakano Citation (outstanding scientific publication), National Center for Infectious Diseases,
Centers for Disease Control and Prevention.
1997
The Scientist: “Hot Paper” designation for publication of: Tenover, F.C. et al. Criteria for interpreting
pulsed-field gel electrophoresis patterns. J Clin Microbiol 33:2233-2239, 1995.
1996
James H. Nakano Citation (outstanding scientific publication), National Center for Infectious Diseases,
Centers for Disease Control and Prevention.
1995
Public Health Service Outstanding Unit Citation, CDC
1994-1996
American Society for Microbiology Foundation Lecturer
1994-Present
Fellow, Infectious Diseases Society of America
1992-Present
Fellow, American Academy of Microbiology
1992-2001
Sigma Xi, Research Honor Society
1985
Visiting Scientist, Armed Forces Research Institute for Medical Sciences, Bangkok, Thailand
1979
American Society for Microbiology President's Fellowship, University of Rochester, Rochester, N.Y.
1977-1980
National Research Service Award Trainee, University of Rochester, Rochester, N.Y.
1976
Summa Cum Laude Graduate, University of Dayton, Dayton, Ohio
1976
John E. Dlugos, Jr. Memorial Award of Excellence in Biology, University of Dayton
Patents
2002 Australian Patent #33723/99: Oligonucleotide probes for detecting Enterobacteriaceae and quinolone-resistant
Enterobacteriaceae
2003 U.S. Patent #6,706,475: Oligonucleotide probes for detecting Enterobacteriaceae and quinolone-resistant
Enterobacteriaceae
Congress/Meeting Organization
2013
Co-organizer, 3rd ASM Conference on Emerging Technologies, Izmir, Turkey
2010-2011
ECCMID Planning Committee, European Society for Clinical Microbiology and Infectious Diseases
3
2010
2008-2009
2008
2005
2004
1997
1996-1997
1994-1995
1993
Editorial Boards
2012-present
1989-1992
2009-present
1985-Present
1994-Present
1996-2008
1993-2003
and 1985-1989
Chair, Emerging Technologies of Medical Importance Conference. American Society for Microbiology,
Cancun, Mexico
International Scientific Advisory Committee, International Congress of Chemotherapy and Infection,
Toronto, Canada
Co-Chair, Emerging Technologies of Medical Importance for the Diagnosis of Infectious Diseases and the
Detection of Pathogenic Microbes. Beijing. China
Organizing Committee, 7th International Meeting on Microbial Epidemiologic Markers (IMMEM-7),
Victoria, British Columbia, Canada
Scientific Advisory Committee, 6th International Meeting on Microbial Epidemiologic Markers (IMMEM6), Les Diablerais, Switzerland
Co-chair, ASM Conference on Molecular Diagnostics and Therapeutics, Kananaskis, Canada
International Scientific Advisory Committee, International Congress of Chemotherapy, Sydney
International Scientific Advisory Committee, International Congress of Chemotherapy, Montreal
Co-chair, ASM Conference on Molecular Diagnostics and Therapeutics, Moran, Wyoming
Editorial Board, Journal of Global Antimicrobial Resistance
Editor, Journal of Clinical Microbiology
Editorial Board, International Journal of Antimicrobial Agents
Editorial Board, Antimicrobial Agents and Chemotherapy
Editorial Board, Microbial Drug Resistance
Editorial Board, Current Opinion in Microbiology
Editorial Board, Journal of Clinical Microbiology
Ad Hoc Reviewer
Proceedings of the National Academy of Science
Science
New England Journal of Medicine
Journal of Infectious Diseases
Clinical Infectious Diseases
Journal of the American Medical Association
Journal of Antimicrobial Chemotherapy
American Journal of Medicine
Annals of Internal Medicine
Emerging Infectious Diseases Journal
European Journal of Clinical Microbiology and Infectious Diseases
Applied and Environmental Microbiology
Plasmid
Infection Control and Hospital Epidemiology
Southern Medical Journal
Trends in Microbiological Sciences
Clinical Microbiology and Infection
Wellcome Trust
International Committees
2010-2011
Scientific Advisory Committee, European Congress of Clinical Microbiology and Infectious Diseases
2009-2013
International Society for Chemotherapy, Executive Committee
2007
Organizing Committee, 19th International Congress on Chemotherapy, 2009, Toronto, Canada
2004-2006
ISO (International Standards Organization) Committee on Global Standardization of Antimicrobial
Susceptibility Testing
1994-2003
World Health Organization, Consultant on Antimicrobial Resistance Monitoring
4
National Committees
2012-Present
Infectious Diseases Society of America, Rapid Diagnostics Working Group
2007-2012
Infectious Diseases Society of America, Antimicrobial Resistance Working Group
2008-2010
Co-Chair, Clinical and Laboratory Standards Institute, Surveillance for Methicillin-Resistant
Staphylococcus aureus: Principles, Practices, and Challenges; A Report
2007-Present
Clinical and Laboratory Standards Institute, Consensus Committee on Microbiology, Voting Member
2007-2010
Clinical and Laboratory Standards Institute (formerly National Committee for Clinical Laboratory
Standards) Subcommittee on Antimicrobial Susceptibility Testing, Advisor
2004-2008
Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA); National Institutes of Health,
Executive Committee
2004-2006
Member, U.S. Delegation, International Standards Organization (ISO) Working Group 4, Antimicrobial
Susceptibility Testing
1994-2006
Clinical and Laboratory Standards Institute (formerly National Committee for Clinical Laboratory
Standards) Subcommittee on Antimicrobial Susceptibility Testing, Voting Member
1991-2008
Clinical and Laboratory Standards Institute (formerly National Committee for Clinical Laboratory
Standards) Subcommittee on Antimicrobial Susceptibility Testing Working Group on Fastidious Pathogens
and Working Group on Staphylococci, Chair and Voting Member (1994-present)
2008-2010
Chair, American Society for Microbiology, Conferences Committee
2006-2007
Vice-Chair, American Society for Microbiology, Conferences Committee
1994-2005
Member, American Society for Microbiology, Conferences Committee
2007-Present
Member, American Society for Microbiology, International Committee
1999-2001
Infectious Diseases Society of America, Emerging Infections Committee
1998-2002
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Program Committee
1996-2006
Food and Drug Administration Microbiology Advisory Panel
1996-2002
Institute of Medicine Panel on Emerging Antimicrobial Resistance
1995-2000
CDC/USDA/FDA Taskforce on Antimicrobial Resistance
1994-2000
American Society for Microbiology, Task Force on Antimicrobial Resistance
1994-1997
Infectious Diseases Society of America, Antibiotic Use and Clinical Trials Committee
1992-2001
National Committee for Clinical Laboratory Standards Subcommittee on Molecular Microbiology, Voting
Member
1991-1993
National Committee for Clinical Laboratory Standards Subcommittee on Antimicrobial Susceptibility
Testing Working Group on Enterococci, Voting Member
1989-1992
American Society for Microbiology, Committee on Post-Doctoral Education, ABMM part I Examination
1991
U.S. Consensus panel on Type-I beta-lactamases
Centers for Disease Control and Prevention
2007-2008
CDC Executive Leadership Board, Compensation and Performance Review Subcommittee
2003-2008
CDC Senior Biomedical Research Service/Title 42 Distinguished Consultants Credentials Committee
1998-2008
Antimicrobial Resistance Working Group, National Center for Infectious Diseases
2000-2002
Building 18 (Infectious Diseases and Bioterrorism Laboratories) Core Design Working Group
1998-2000
Building 17 (Infectious Diseases Laboratories) Core Design Working Group
1993-1997
Chair, Antimicrobial Resistance Working Group, NCID
1991-1993
National Center for Infectious Diseases Speakers Committee
Veterans Affairs Medical Center, Seattle
1988-1990
Scientific Review and Evaluation Committee
1988-1990
Long Range Planning Committee for Research and Development
1985-1990
Biomedical Safety Officer for General Medical Research
1984-1990
Hospital Infection Control Committee
1982-1988
Research and Development Computer Subcommittee
1984-1988
Committee on Biosafety Level 3 (P-3) Facility Use
5
University of Washington, Seattle
1986-1988
Faculty Senator
1987
Chairman, "Perspectives in Clinical Microbiology." Continuing Medical Education Course and
Symposium, University of Washington.
1985
Chairman, "New Methods in Diagnostic Laboratory Medicine." Continuing Medical Education Course,
University of Washington.
Professional Societies
American Society for Microbiology
American Academy of Microbiology
Infectious Diseases Society of America
American Association for the Advancement of Science (1980-2003)
Society of Healthcare Epidemiologists of America (1990-1998)
Academy of Clinical Laboratory Physicians and Scientists (1990-1995)
Veterans Administration Society for Practitioners of Infectious Diseases (1988-1990)
Current Research
1.
Characterization of novel antimicrobial resistance genes in bacterial pathogens.
2.
Development of molecular techniques for rapid diagnosis of infectious diseases
3.
Development of novel methods of detecting antimicrobial resistance in bacteria in clinical laboratories.
4.
Development and assessment of novel techniques for bacterial strain typing.
5.
Use of molecular techniques for epidemiological studies of bacterial infections.
Peer-reviewed Publications
1.
Tenover FC, Mayer LW, and Young FE: Physical map of the conjugal plasmid of Neisseria gonorrhoeae. Infect
Immun. 29:181-187, 1980.
2.
Tenover FC, Clark VL, and Young FE: Presence of methyl adenine in the DNA of some strains of Neisseria
gonorrhoeae. Biochem Biophys Res Commun. 95:1796-1800, 1980.
3.
Kolodkin A, Clark VL, Tenover FC, and Young FE: High correlation of the presence of methyladenine in
Neisseria gonorrhoeae with the AHU auxotype. Infect Immun. 36:586-590, 1982.
4.
Biswas GD, Graves JF, Sox TE, Tenover FC, and Sparling PF: Marker rescue by a homologous recipient plasmid
during transformation of gonococci by a hybrid Pc r plasmid. J Bacteriol. 151:77-82, 1982.
5.
Tenover FC, Bronsdon MA, Gordon KP, and Plorde: Isolation of plasmids encoding tetracycline resistance from
Campylobacter jejuni strains isolated from simians. Antimicrob Agents Chemother. 23:320-322, 1983.
6.
Stein DC, Young FE, Tenover FC, and Clark VL: Characterization of a chimeric β -lactamase plasmid of
Neisseria gonorrhoeae which can function in Escherichia coli. Mol Gen Genet. 189:77-84, 1985.
7.
Lipsky BA, Gates J, Tenover FC, and Plorde JJ: Factors affecting the clinical value of direct microscopy for acid
fast bacilli. Rev Infect Dis. 6:214-221, 1984.
8.
Tenover FC, Williams S, Gordon KP, Harris N, Nolan C, and Plorde JJ: Utility of plasmid fingerprinting for
epidemiological studies of Campylobacter jejuni infections. J Infect Dis. 148:279, 1984.
9.
Nolan CM, Ballard J, Kaysner CA, Lilja JL, Williams LP, and Tenover FC: Vibrio parahemolyticus gastroenteritis:
An outbreak associated with raw oysters in the Pacific Northwest. Diagnostic Microbiol Infect Dis. 2:119-128,
1984.
6
10.
Tenover FC: Plasmid fingerprinting: A rapid bacterial typing technique. Laboratory Management. 22:49-56,
1984.
11.
Tenover FC, Gootz TD, Gordon KP, Tompkins LS, Young SA, and Plorde JJ: Development of a DNA probe for
the structural gene of the 2"-0-adenyltransferase aminoglycoside-modifying enzyme. J Infect Dis. 150:678-687,
1984.
12.
Tenover FC, and Plorde JJ: Occurrence of the "mutabile" phenotype in a blood culture isolate. Clin Microbiol
Newsletter. 6:152-153, 1984.
13.
Totten PA, Fennell CL, Tenover FC, Wezenberg JM, Perine PL, Stamm WE, and Holmes KK: Two new
Campylobacter species, C. cinaedi sp. nov. and C. fennelliae sp. nov. associated with enteric disease in homosexual
men. J Infect Dis. 151:131-139, 1985.
14.
Tenover FC, William S, Gordon KP, Nolan C, and Plorde JJ: Survey of plasmids and resistance factors in
Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 27:37-41, 1985.
15.
Tenover FC
-lactamase
plasmids of Neisseria gonorrhoeae with altered ability to be mobilized during conjugation. Sexually Trans Dis.
12:76-82, 1985.
16.
Tenover FC, Knapp JS, Patton C, and Plorde JJ: Use of auxotyping for epidemiological studies of Campylobacter
jejuni and Campylobacter coli infections. Infect Immun. 48:384-388, 1985.
17.
Carlson LG, Tenover FC, and Plorde JJ: Increased detection of staphylococcal bacteremia using an antimicrobial
removal device. Am J Clin Path. 84:509-512, 1985.
18.
Young SA, Tenover FC, Gootz TD, Gordon KP, and Plorde JJ: Development of two DNA probes for differentiating
the structural genes of subclasses I and II of the aminoglycoside-modifying enzyme 3'-aminoglycoside
phosphotransferase. Antimicrob Agents Chemother. 27:739-744, 1985.
19.
Gootz TD, Tenover FC, Young SA, Gordon KP, and Plorde JJ: Comparison of three DNA hybridization methods
for detecting the aminoglycoside 2"-0-adenyltransferase gene in clinical isolates of bacteria. Antimicrob Agents
Chemother. 28:69-73, 1985.
20.
Lipsky BA, Plorde JJ, Tenover FC, and Brancato F: Comparison of the Automicrobic system, acridine orange
stained smears and gram-stained smears in detecting bacteriuria. J Clin Microbiol. 22:176-181, 1985.
21.
Tenover FC, Carlson LG, Goldstein L, Sturge J, and Plorde JJ: Confirmation of Legionella pneumophila cultures
with a fluorescein-labelled monoclonal antibody. J Clin Microbiol. 21:983-984, 1985.
22.
Mickelsen PA, Plorde JJ, Gordon KP, Hargiss D, McClure J, Schoenkneckt FD, Condie F, Tenover FC, and
Tompkins LS: Instability of antibiotic resistance in a strain of Staphylococcus epidermidis isolated from an
outbreak of prosthetic valve endocarditis. J Infect Dis. 15:50-58, 1985.
23.
Tenover FC: Plasmid fingerprinting: A tool for bacterial strain identification and surveillance of nosocomial and
community-acquired infections. Laboratory Medicine Clinics in North America. 5:413-436, 1985.
24.
Tenover FC: DNA probes for diagnosis of infectious diseases. Clin Microbiol Newsletter. 7:105-108, 1985.
25.
Plorde JJ, Carlson LG, and Tenover FC: Specimen volume versus yield in the BACTEC blood culture system. J
Clin Microbiol. 22:292-295, 1985.
7
26.
Tenover FC, Edelstein PH, Goldstein LC, Sturge JC, and Plorde JJ: Comparison of cross-staining reactions of
Pseudomonas spp. and fluorescein-labelled polyclonal and monoclonal antibodies directed against Legionella
pneumophila. J Clin Microbiol. 23:647-649, 1986.
27.
Plorde JJ, Gates JA, Carlson LG, and Tenover FC: Critical evaluation of the Automicrobic system gram-negative
identification card for identification of glucose-nonfermenting gram-negative rods. J Clin Microbiol. 23:251-257,
1986.
28.
Blaser MJ, Guillermo PP, Smith PF, Patton C, Tenover FC, Lastovica AJ, and Wang W-L: Extraintestinal
Campylobacter jejuni and Campylobacter coli infections: Host factors and strain characteristics. J Infect Dis.
153:552-559, 1986.
29.
Tenover FC: Studies of antimicrobial resistance genes using DNA probes. Antimicrob Agents Chemother.
29:721-725, 1986.
30.
Totten PA, Patton CM, Tenover FC, Barrett TJ, Stamm WE, Steigerwalt AG, Lin JY, Holmes KK, and Brenner DJ:
Prevalence and characterization of hippurate-negative Campylobacter jejuni in King County, Washington. J Clin
Microbiol. 25:1747-1752, 1987.
31.
Tenover FC, LeBlanc DJ, and Elvrum P: Cloning and expression of a tetracycline resistance determinant from
Campylobacter jejuni in Escherichia coli. Antimicrob Agents Chemother. 31:1301-11306, 1987.
32.
Tenover FC and Patton CM: Naturally occurring auxotrophs of Campylobacter jejuni and Campylobacter coli. J
Clin Microbiol. 25:1659-1661, 1987.
33.
Tenover FC, Filpula D, Phillips KL, and Plorde JJ: Cloning and sequencing of a gene encoding an aminoglycoside
6'-N-acetyltransferase from an R factor of Citrobacter diversus. J Bacteriol. 170:471-473, 1988.
34.
Tenover FC: Diagnostic deoxyribonucleic acid probes for infectious diseases”. Clin Microbiol Rev. 1:82-101,
1988.
35.
Tenover FC, and Gebhart CJ: Isolation and identification of Campylobacter species. Clin Microbiol Newsletter.
10:81-84, 1988.
36.
Tenover FC and Elvrum PM: Detection of two different kanamycin resistance genes in naturally occurring isolates
of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 32:1170-1173, 1988.
37.
LeBlanc DJ, Lee LN, Titmas BM, Smith SJ, and Tenover FC: Nucleotide sequence analysis of tetracycline
resistance gene tetO from Streptococcus mutans strain DL5. J Bacteriol. 170:3618-3626, 1988.
38.
Tenover FC: DNA probes - Where are they taking us? European J Clin Microbiol Infect Dis. 7:457-459, 1988.
39.
Johnson JR and Tenover FC: Clostridium tertium bacteremia in a patient with aspiration pneumonia: An elusive
diagnosis. J Infect Dis. 157:854-855, 1988.
40.
Dennis MB, Jr, Jones DR, and Tenover FC: Chlorine dioxide sterilization of implanted right atrial catheters in
rabbits. Lab Animal Sci. 38:51-55, 1989.
41.
Tenover FC, Phillips KL, Lockhart P, O'Hara PJ, and Plorde JJ: Development of a DNA probe from the
deoxyribonucleotide sequence of an AAC (3')-I aminoglycoside resistance gene. Antimicrob Agents Chemother.
33:551-559, 1989.
8
42.
Tenover FC: DNA probes for antimicrobial susceptibility testing. Clinics Lab Med. 9:341-347, 1989.
43.
Tenover FC: DNA probes for rapid detection of infectious agents. Resident & Staff Physician. 35:35-37, 1989.
44.
Tenover FC, Gilbert T, and O'Hara P: Nucleotide sequence of a novel kanamycin resistance gene, aphA-7, from
Campylobacter jejuni and comparison to other kanamycin phosphotransferase genes. Plasmid. 22:52-58, 1989.
45.
Coll P, Phillips K, and Tenover FC: Evaluation of a rapid method of extracting DNA from stool samples for use in
hybridization assays. J Clin Microbiol. 27:2245-2248, 1989.
46.
Campos J, Chanyangam M, deGroot R, Smith AL, Tenover FC, and Reig R: Genetic relatedness of antibiotic
resistance determinants in multiresistant Haemophilus influenzae. J Infect Dis. 160:810-817, 1989.
47.
Dennis MB, Jr, Jones DR, and Tenover FC: Sepsis of vascular catheters II: In vitro disinfection of colonized
tubing. J Biomed Material Res. 24:95-105, 1990.
48.
Tenover FC, Carlson L, Barbagallo S, and Nachamkin I: DNA probe culture confirmation assay for identification of
thermophilic Campylobacter species. J Clin Microbiol. 28:1284-1287, 1990.
49.
Tenover FC, Mizuki T, and Carlson L: Evaluation of the MicroScan Walkway for identification of non-glucose
fermenting gram-negative bacilli. J Clin Microbiol. 28:1628-1634, 1990.
50.
Tenover FC: Novel and emerging mechanisms of antimicrobial resistance. Am J Med. Suppl 3B:765-815, 1991.
51.
Smith MS, Mitchell J, Corey L, Gold D, McCauley EA, Glover D, and Tenover FC: Chronic fatigue in
adolescents. Pediatrics. 88:195-202, 1991.
52.
Fasching CE, Tenover FC, Slama TG, Fisher LM, and others: gyrA mutation in ciprofloxacin-resistant, methicillinresistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee. J Infect Dis. 164:976-9, 1991.
53.
Matar GM, Gay E, Cooksey RC, Elliott JA, Heneine WM, Uwaydah MM, Matossian RM, and Tenover FC:
Identification of an epidemic strain of Acinetobacter baumannii using electrophoretic typing methods. Eur J
Epidemiol. 8:9-14, 1992.
54.
Tenover FC, Fennell C, Lee L, and LeBlanc DL: Characterization of Campylobacter plasmids encoding the aphA7 kanamycin resistance gene. Antimicrob Agents Chemother. 36:712-716, 1992.
55.
Swenson JM, Ferraro MJ, Sahm DF, Charache P, NCCLS Working Group on Enterococci, and Tenover FC: New
vancomycin disk diffusion breakpoints for enterococci. J Clin Microbiol 30:2525-2528, 1992.
56.
Gordon S, Swenson JM, Hill BC, Pigott NE, Facklam RR, Cooksey RC, Thornsberry C, Enterococcal Study Group,
Jarvis WR, and Tenover FC: Antimicrobial susceptibility patterns of common and unusual species of enterococci
causing infections in the United States. J Clin Microbiol. 30:2373-2378.
57.
McDougal LK, Facklam RR, Reeves M, Hunter S, Swenson JM, Hill BC, and Tenover FC: Analysis of multiply
antimicrobial resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob Agents
Chemotherapy. 36:2176-2184, 1992.
58.
Huang M-B, Baker CN, Banerjee S, and Tenover FC: Accuracy of the E Test for determining the antimicrobial
susceptibility of Staphylococci, Enterococci, Campylobacter jejuni and antimicrobial resistant enteric gram-negative
bacteria. J. Clin Microbiol. 30:3243-3248, 1992.
59.
Tenover FC, Swenson JM, and McDougal LK. Screening for extended spectrum cephalosporin resistance in
9
pneumococci (letter). Lancet 340:1420, 1992.
60.
Tenover FC: Bauer and Kirby meet Watson and Crick. Antimicrobial susceptibility testing in the molecular era.
ASM News. 58:669-672, 1992.
61.
Sloas MM, Barrett FF, Chesney PJ, English BK, Hill BC, Tenover FC, and Leggiadro RJ: Cephalosporin treatment
failure in penicillin- and cephalosporin-resistance streptococcus pneumoniae meningitis. Ped Infect Dis Journal.
11:662-6, 1992.
62.
Neu HC, Duma RJ, Jones RN, McGowan JE, Jr., O'Brien TF, Sabath LD, Sanders CC, Schaffner W, Tenover FC,
and Young LS: Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase
resistance. Diag Microbiol & Infect Dis. 15:49S-52S, 1992.
63.
Flamm RK, Phillips KL, Tenover FC, and Plorde JJ: A survey of clinical isolates of Enterobacteriaceae using a
series of DNA probes for aminoglycoside resistance genes. Antimicrob Agents Chemother. Molec Cell Probes.
7:139-144, 1993.
64.
Olsvik B and Tenover FC: Tetracycline resistance in periodontal pathogens. Clin Infect Dis. 16:5310-5313, 1993.
65.
Tenover FC: DNA hybridization techniques and their application to the diagnosis of infectious diseases. Infect Dis
Clinics North Am. 7:171-181, 1993.
66.
Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh CR, Jr., and Good RC: The resurgence of
tuberculosis: Is your laboratory ready? J Clin Microbiol. 31:767-70, 1993.
67.
Tenover FC: Antimicrobial susceptibility testing of Neisseria meningitidis. Clin Microbiol Newsletter. 15:37-38,
1993.
68.
Tenover FC, Tokars J, Swenson JM, Paul S, Spitalny K, and Jarvis W: Ability of clinical laboratories to detect
antimicrobial resistant enterococci. J Clin Microbiol. 31:1695-1699, 1993.
69.
Barry AL, Fuchs FC, Jorgensen JH, Tenover FC, Allen SD, Hardy DJ, and McLaughlin JC: Susceptibility of
Haemophilus influenzae to piperacillin-tazobactam combinations; Interpretive criteria and quality control limits for
standardized tests. J Clin Microbiol. 31:751-753, 1993.
70.
Barry AL, Fuchs PC, Allen SD, Jorgensen JH, Tenover FC, Murray PR, Hardy DJ and Baker CN: Tentative
criteria for confirming the in vitro susceptibility of Haemophilus influenzae and Neisseria gonorrhoeae to two
fluoroquinolones (Sparfloxacin and Levofloxacin) including quality control parameters. J Clin Microbiol. 31:39240,1993.
71.
Barry AL, Pfaller MA, Fuchs PC, Tenover FC, Reller LB, Allen SD, Hardy DJ, and Gerlach EH: Interpretive
criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine. Eur J
Clin Microbiol Infect Dis. 12:352-256, 1993.
72.
Huang M-B, Gay TE, Baker CN, Banerjee SN, and Tenover FC: Two percent sodium chloride is required for
susceptibility testing of staphylococci with oxacillin when using agar-based dilution methods. J Clin Microbiol.
31:2683-2688, 1993.
73.
O'Hara CM, Tenover FC, and Miller JM: Parallel comparison of accuracy of API 20E, Vitek GNI, MicroScan
Walk/Away Rapid ID, and Becton Dickinson Cobas Micro ID-E/NF for identification of members of the family
Enterobacteriaceae and common gram-negative, non-glucose-fermenting bacilli. J Clin Microbiol. 31:3165-3169,
1993.
10
74.
Daum RS, Nachman JP, Leitch CD, and Tenover FC: Nosocomial epiglottitis associated with penicillin- and
cephalosporin-resistant Streptococcus pneumoniae bacteremia. J Clin Microbiol. 32:246-248, 1994.
75.
Clark NC, Cooksey RC, Hill BC, Swenson JM, and Tenover FC: Characterization of glycopeptide-resistant
enterococci from U.S. hospitals. Antimicrob Agents Chemother. 37:2720-2725, 1993.
76.
Jorgensen JH, Ferraro MJ, McElmeel ML, Spargo J, Swenson JM, and Tenover FC: Detection of penicillin and
extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test.
J Clin Microbiol. 32:159-163, 1994.
77.
Jackson LA, Tenover FC, Baker C, Plikaytis BD, Reeves MW, Stocker SA, Weaver RE, Wenger JD, and the
meningococcal disease study group: Prevalence of Neisseria menigitidis relatively resistant to penicillin in the
United States, 1991. J Infect Dis. 169:438-441, 1994.
78.
Weber JT, Mintz ED, Canizares R, Semiglia A, Gomez I, Tenover FC, Tauxe RV, and Blake PA: Epidemic
cholera in Ecuador: multi-drug-resistance and transmission by water and seafood. Epidemiol Infect 112:1-11, 1994.
79.
Tenover FC, Arbeit R, Archer G, Biddle J, Byrne S, Goering R, Hancock G, Hebert GA, Hill B, Hollis R, Jarvis
WR, Kreiswirth B, Eisner W, Maslow J, McDougal LK, Miller JM, Mulligan M, and Pfaller MA: Comparison of
traditional and molecular methods of typing isolates of Staphylococcus aureus. J Clin Microbiol. 32:407-415, 1994.
80.
Jorgensen JH, Swenson JM, Tenover FC, Ferraro MJ, Hindler JA, and Murray PR: Development of interpretive
criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of
Streptococcus pneumoniae. J Clin Microbiol. 32:2448-2459, 1994.
81.
Ries AA, Wells JG, Olivola D, Ntakibirora M, Nyandwi S, Ntibakivayo M, Ivey CB, Greene KD, Tenover FC,
Wahlquist SP, Griffin PM, and Tauxe RV: Epidemic Shigella dysenteriae type 1 in Burundi: pan-resistance and the
implications for prevention. J Infect Dis. 169:1035-1041, 1994.
82.
Leggiadro RJ, Barrett FF, Chesney PJ, Davis Y, Tenover FC: Invasive pneumococci with high penicillin and
cephalosporin resistance at a Mid-South children's hospital. Ped Infect Dis J. 13:320-322, 1994
83.
Tenover FC, Huang MB, Rasheed JK, and Persing DH: Development of PCR assays to detect ampicillin resistance
genes in cerebrospinal fluid samples containing Haemophilus influenzae. J Clin Microbiol 32:2729-2737, 1994.
84.
Swenson J, Clark N, Ferraro MJ, Sahm DF, Doern G, Pfaller MA, Reller LB, Weinstein MP, Zabransky RJ, and
Tenover FC: Development of a standardized screening method for detection of vancomycin-resistant enterococci. J
Clin Microbiol 32:1700-1704, 1994.
85.
Breiman RF, Butler JC, Tenover FC, Elliot JE, Facklam RR: Emergence of drug-resistant pneumococcal infections
in the United States. JAMA 271:831-1835, 1994.
86.
Olsvik B, Olsen I, and Tenover FC: The tet(Q) gene in bacteria isolated from patients with refractory periodontal
disease. Oral Microbiol Immunol 9:251-255, 1994.
87.
Sader HS, Pfaller MA, Tenover FC, Hollis RJ, and Jones RN: Evaluation and characterization of multiresistant
Enterococcus faecium from 12 U.S. medical centers. J Clin Microbiol 32:2840-2842, 1994.
88.
Baker CN, Huang MB, Tenover FC: Optimizing testing of methicillin-resistant Staphylococcus species. Diag
Microbiol Infect Dis 19:167-170, 1994.
89.
Barry A, Fuch P, Tenover F, Allen S, hardy D, Jorgensen J, McLaughlin J, Reller L: Interpretive criteria and quality
control for antimicrobial susceptibility test for levofloxacin. Eur J Clin Microbiol Infect Dis. 13:822-826, 1994.
11
90.
Tenover FC: Using DNA probes and the polymerase chain reaction to detect and identify antimicrobial resistance
genes. J Assn Rapid Methods Automation Microbiology 6:1-10, 1994.
91.
Tompkins LS, Tenover F, Arvin A: New technology in the clinical laboratory; what you always wanted to know but
were afraid to ask. J Infect Dis. 170:1068-1074, 1994.
92.
Barry AL, Fuchs PC, Allen SD, Tenover FC, Jorgensen JH, Reller LB: Interpretive criteria and quality control
parameters for testing bacterial susceptibility to the fluoroquinolone PD13128. J Clin Microbiol. 33:235-238, 1995.
93.
Haley RW, Cushion NB, Tenover FC, Bannerman TL, Dryer D, Ross J, Sanchez PJ, Siegel JD: Eradication of
endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J. Infect. Dis.
171:614-624, 1995.
94.
Bannerman TL, Hancock GA, Tenover FC, and Miller JM: Pulsed-field gel electrophoresis as a replacement for
bacteriophage typing of Staphylococcus aureus. J Clin Microbiol 33:551-555, 1995.
95.
Olsvik B, Olsen I, Tenover FC: Detection of tet(M) and tet(O) using the polymerase chain reaction in bacteria
isolated from patients with periodontal disease. Oral Microbiol Immunol. 10:87-92, 1995.
96.
Olsvik B, Hansen BF, Tenover FC, and Olsen I: Tetracycline-resistant microorganisms recovered from patients
with refractory periodontal disease. J Clin Periodontol 22:391-396, 1995.
97.
van Belkm A, Kluytmans J, van Leewen W, Bax R, Quint W, Peters E, Fluit A, Vandenbroucke-Grauls C, van den
Brule A, Koelman H, Melchers W, Meis J, Elaichouni A, Vaneechoutte M, Moonens F, Maes N, Struelens M,
Tenover F, and Verbrugh H: Multi-center evaluation of arbitrary primed polymerase chain reaction for typing of
Staphylococcus aureus strains. J Clin Microbiol 33:1537-1547, 1995.
98.
Tenover FC, Swenson JM, O'Hara CM, and Stocker SA: Ability of commercial and reference antimicrobial
susceptibility testing methods to detect vancomycin resistance in enterococci. J Clin Microbiol 33:1524-27, 1995.
99.
Lewis K, Saubolle MA, Tenover FC, Rudinsky MF, Barbour SD, Cherry JD: Pertussis caused by an erythromycinresistant strain of Bordetella pertussis. Pediatr Infect Dis J. 14:388-391, 1995.
100.
Coffey TJ, Daniels M, McDougal LK, Tenover FC, Spratt BG: Genetic analysis of clinical isolates of
Streptococcus pneumoniae with high level resistance to extended spectrum cephalosporins. Antimicrob Agents
Chemother. 39:1306-1313, 1995.
101.
Cleveland KO, Threlkeld MG, Tenover FC, Leggiadro RJ: Drug-resistant pneumococcal meningitis in an American
adult. Clin Infect Dis. 20:1572-1573, 1995.
102.
Sewell DL, Barry AL, Allen SD, Fuchs PC, Jorgensen JH, Tenover F: Tentative criteria for determining the in vitro
susceptibilities of Haemophilus influenzae, including quality control parameters, for two fluoroquinolones
(Grepafloxacin and PD 131628). Diag Microbiol Infect Dis. 21:175-179, 1995.
103.
Welbel SF, Schoendorf K, Bland L, Arduino MJ, Groves C, Schable B, O'Hara CM, Tenover FC, Jarvis WR: An
outbreak of gram-negative bloodstream infections in chronic hemodialysis patients. Am J Nephrol. 15:1-4, 1995.
104.
Swenson JM, Sahm DF, Ferraro MJ, Doern G, Hindler J, Jorgensen JH, Pfaller MA, Reller LB, Weinstein MP,
Zabransky RJ, and Tenover FC: Molecular characterization and multi-laboratory evaluation of Enterococcus
faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside
resistance in enterococci. J Clin Microbiol 33:3019-3012, 1995.
12
105.
Swenson JM, Ferraro MJ, Sahm DF, Clark NC, Culver DH, and Tenover FC: Multi-laboratory evaluation of
screening methods for detection of high-level aminoglycoside resistance in enterococci. J Clin Microbiol 33:30083018, 1995.
106.
Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, and Swaminathan B: Interpreting
chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: Criteria for bacterial strain
typing. J Clin Microbiol 33:2233-2239, 1995.
107.
Fuchs PC, Barry AL, Tenover FC, Allen SD, Jorgensen JH, Murray PR: Tests for susceptibility of Streptococcus
pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for broth microdilution and
disc diffusion methods. J Antimicrob Chemother. 36:781-786, 1995.
108.
Tenover FC. The best of times, the worst of times. The global challenge of antimicrobial resistance. Pharmacy
World & Science. 17:149-51, 1995.
109.
Kruse H, Sørum H, Tenover FC, Olsvik Ø: A transferable multiple drug resistance plasmid from Vibrio cholerae.
Microbial Drug Resistance 1:203-210, 1995.
110.
Tenover FC: Emerging problems in antimicrobial resistance. J Intravenous Nursing. 18:297-300, 1995.
111.
McDougal LK, Rasheed JK, Biddle JW, Tenover FC: Identification of multiple clones of extended-spectrum
cephalosporin-resistant Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 39:22822288, 1995.
112.
Tenover FC, Hughes JM. WHO Scientific Working Group on monitoring and management of bacterial resistance
to antimicrobial agents. Emerg Infect Dis. 1:37, 1995
113.
Tenover FC, McGowan JE, Jr: Reasons for the emergence of antibiotic resistance. Am J Med Sciences 311:9-16,
1996.
114.
Sewell DL, Barry AL, Allen SD, Fuchs PC, Murray PR, Tenover FC: Tentative interpretive criteria and quality
control parameters for in vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628
and Grepafloxacin [OPC 17116]). J Antimicrob Chemother. 37:139-143, 1996.
115.
Barry AL, Fuchs PC, Allen SD, Brown SD, Jorgensen JH, Tenover FC: In-vitro susceptibility of Streptococcus
pneumoniae to the d- and l- isomers of ofloxacin: interpretive criteria and quality control limits. J Antimicrob
Chemother. 37:365-369, 1996.
116.
Baker CN, and Tenover FC: Evaluation of the Alamar colorimetric MIC system for gram positive organisms. J Clin
Microbiol 34:2654-2659, 1996.
117.
Arnold KE, Leggiadro RJ, Breiman RF, Lipman HB, Schwartz B, Appleton MA, Cleveland KO, Szeto HC, Hill BC,
Tenover FC, Elliott JA, Facklam RR: Risk factors for carriage of drug-resistant Streptococcus pneumoniae among
children in Memphis, Tennessee. J Peds. 128:757-764, 1996.
118.
Jorgensen JH, Swenson JM, Tenover FC, Barry A, Ferraro MJ, Murray PR, Reller LB. Development of interpretive
criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.
J Clin Microbiol. 34:2679-2684, 1996.
119.
Tenover FC, Hughes JM: The challenges of emerging infectious diseases: development and spread of multiply
resistant bacterial pathogens. JAMA 275:300-304, 1996.
120.
Tenover FC, Baker CN, Swenson JM: Evaluation of commercial methods for determining antimicrobial
13
susceptibility of Streptococcus pneumoniae. J Clin Microbiol 34:10-14, 1996.
121.
Olsvik B, Flynn MJ, Tenover FC, Slots J,Olsen I. Tetracycline resistance in Prevotella isolates from periodontally
diseased patients is due to the tet(Q) gene. Oral Microbiol Immunol 11:304-8, 1996
122.
Hughes JM, Tenover FC: Infectious disease challenges of the 1990s. Infect in Medicine. 9:788-799, 1997.
123.
Tenover FC, Hughes JM: Approached to limiting emergence of antimicrobial resistance in bacterial in human
populations. Clin Infect Dis. 24:S131-135, 1997.
124.
Rasheed JK, Jay C, Metchock B, Berkowicz F, Hill B, Tenover FC: Evolution of extended-spectrum beta-lactam
resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents
Chemother 41:647-653, 1997.
125.
Tenover FC, Baker CN: Development of provisional disk diffusion breakpoints for testing RP59500
(Quinupristin/Dalfopristin). J Antimicrob Chemother. 39 (Suppl A): 81-85, 1997.
126.
Tenover FC, Arbeit RD, Goering RV and the Molecular Typing Working Group: How to select and interpret
molecular strain typing methods for epidemiologic studies of bacterial infections: a review for health care
epidemiologists. Infect Control Hosp Epidemiol.18:426-439, 1997.
127.
McGowan JE, Tenover FC: Control of antimicrobial resistance in the health care system. Infect Dis Clinics North
Amer. 11:297-311, 1997.
128.
Monnet DL, Biddle JW, Edwards JR, Culver DH, Tolson JS, Martone WJ, Tenover FC, Gaynes RP: Evidence of
interhospital transmission of extended-spectrum β-lactam-resistant Klebsiella pneumoniae in the United States,
1986-1993. Infect Control Hosp Epi 18:492-498, 1997.
129.
Shlaes DM, Gerding D, John JF, Craig W, Bornsterin D, Duncan R, Eckman M, Farrer W, Greene W, Lorian V,
McGowan J, Paul S, Tenover F, Watanakunakorn C, Ruskind J: Guidelines for the prevention of antimicrobial
resistance in hospitals. Infect Control Hosp Epidemiol. 18:275-91, 1997.
130.
Sataki S, Clark N, and Tenover FC: Use of PCR to detect vancomycin resistant enterococci directly in stool
samples. J Clin Microbiol 35:2325-2330, 1997.
131.
Styrt BA, Shinnick TM, Ridderhof JC, Crawford JT, Tenover FC. Turnaround times for mycobacterial cultures
[letter]. J Clin Microbiology. 35:1041-1042, 1997.
132.
Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R. Antimicrobial resistance in isolates
from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect
Dis 24:211-215, 1997.
133.
Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus
clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135-136, 1997.
134.
McDonald LC, Kuehnert MJ, Tenover FC, Jarvis WR. Vancomycin-resistant enterococci outside the health-care
setting: prevalence, sources, and public health implications. Emerging Infect Dis 3:311-317, 1997.
135.
Samore M, Killgore G, Johnson S, Goodman R, Shim J, Venkataraman L, Sambol S, DeGirolami P, Tenover F,
Arbeit R, Gerding D. Multicenter typing comparison of sporadic and outbreak Clostridium difficile isolates from
geographically diverse hospitals. J Infect Dis. 176:1233-8, 1997.
136.
Reichmann P, Konig A, Linares J, Alcaide F, Tenover FC, McDougal L, Swidsinski S, Hakenbeck R. A global
14
gene pool for high-level cephalosporin resistance in commensal Streptococcus species and Streptococcus
pneumoniae. J Infect Dis. 176:1001-1012, 1997.
137.
Fuchs PC, Barry AL, Brown SD, Allen SD, Bauman M, Jorgensen JH, Tenover FC. Reproducibility of broth
microdilution and disk diffusion susceptibility tests of nine antimicrobial agents against Streptococcus pneumoniae
ATCC 49619. Diagn Microbiol Infect Dis 28:27-29, 1997.
138.
Rosenberg J, Tenover FC, Wong J, Jarvis W, Vugia D. Are clinical laboratories in California accurately reporting
vancomycin resistant enterococci? J Clin Microbiol. 35:2526-2530,1997.
139.
Sahm DF, Tenover FC: Surveillance for the emergence and dissemination of antimicrobial resistance in bacteria.
Infect Dis Clinics North Amer. 11:767-783,1997.
140.
D’Agata E, Venkataraman L, DeGirolami P, Weigel L, Samore M, Tenover F: The molecular and clinical
epidemiology of Enterobacteriaceae producing extended-lactamases in a tertiary care hospital. J
Infect. 36:279-285, 1998.
141.
Clark NC, Teixeira LM, Facklam RR, Tenover FC: Detection and differentiation of vanC-1, vanC-2, and vanC-3
glycopeptide resistance genes in enterococci. J Clin Microbiol 36:2294-2297, 1998.
142.
Van Belkum A, van Leeuwen W, Kaufmann ME, Cookson B, Forey F, Etienne J, Goering R, Tenover F, et al.
Assessment of resolution and intercenter reproducibility of results of genotyping Staphylococcus aureus by pulsedfield gel electrophoresis of SmaI macrorestriction fragments: a multicenter study. J Clin Microbiol 36:1653-1659,
1998.
143.
McDougal LM, Tenover FC, Lee LN, Rasheed JK, Patterson JE, Jorgensen JH, LeBlanc DJ. Detection of Tn917like sequences within a Tn916-like conjugative transposon (Tn3872) in erythromycin-resistant isolates of
Streptococcus pneumoniae. Antimicrob Agents Chemother 42:2312-2318, 1998.
144.
Levin BR, Antia R, Berliner E, Bloland P, Bonhoeffer S, Cohen M, DeRouin T, Fields PI, Jafari H, Jernigan D,
Lipsitch M, McGowan JE Jr, Mead P, Nowak M, Porco T, Sykora P, Simonsen L, Spitznagel J, Tauxe R,
Tenover F. Resistance to antimicrobial chemotherapy: a prescription for research and action. Am J Medical Sci.
315:87-94, 1998.
145.
Weigel LM, Steward CD, Tenover FC. GyrA mutations associated with fluoroquinolone resistance in eight species
of Enterobacteriaceae. Antimicrob Agents Chemother. 42:2661-2667, 1998.
146.
Tenover FC, Lancaster MV, Hill BC, Steward CD, Stocker SA, Hancock GA. Characterization of staphylococci
with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 36:1020-1027, 1998.
147.
Rafferty ME, Baltch AL, Smith RP, Bopp LH, Rheal C, Tenover FC, Killgore GE, Lyerly DM, Wilkins TD,
Schoonmaker DJ, Hannett GE, Shayegani S. Comparison of restriction enzyme analysis, arbitrarily primed PCR,
and protein profile analysis typing for epidemiologic investigation of an ongoing Clostridium difficile outbreak. J
Clin Microbiol 36:2957-2963, 1998.
148.
Daneshvar MI, Hill B, Hollis DG, Moss CW, Jordan JG, MacGregor JP, Tenover F, Weyant RS. 1998. CDC Group
O-3: phenotypic characteristics, fatty acid composition, isoprenoid quinone content, and in vitro antimicrobial
susceptibilities of an unusual gram-negative bacterium isolated from clinical specimens. J Clin Microbiol 36:16741678, 1998.
149.
McGowan J, Jr, Tenover F: Antimicrobial resistance in the intensive care unit: impact of new patterns. International
J Clin Practice 52 (Suppl 95):14-22, 1998.
15
150.
O’Hara CM, Steward CD, Wright JL, Tenover FC, Miller JM. Isolation of Enterobacter intermedium from the
gallbladder of a patient with cholecystitis. J Clin Microbiol 36:3055-3056, 1998.
151.
Nicola FG, McDougal LK, Biddle JW, Tenover FC: Characterization of erythromycin-resistant isolates of
Staphylococcus aureus in the United States from 1958 through 1969. Antimicrob Agents Chemother. 42:3024-3027,
1998.
152.
Jorgensen JH, Weigel LM, Ferraro MJ, Swenson JM, Tenover FC: Activities of newer fluoroquinolones against
Streptococcus pneumoniae clinical isolates including those with mutations in gyrA, parC, and parE loci. Antimicrob
Agents Chemother. 43:329-334, 1999.
153.
Clark NC, Olsvik Ø, Swenson JM, Speigel CA, Tenover FC: Detection of a streptomycin/spectinomycin
adenylyltransferase gene (aadA) in Enterococcus faecalis. Antimicrob Agents Chemother 43:157-160, 1999.
154.
Smith T, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Arduino MJ, Zervos
MJ, Miller JM, Band JD, Jarvis W: Emergence of vancomycin resistance in Staphylococcus aureus: epidemiology
and clinical significance. N Engl J Med 340:493-501, 1999.
155.
Steward CD, Stocker SA, Swenson JM, O’Hara CM, Edwards JR, Gaynes RP, McGowan JE Jr, Tenover FC:
Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods for
detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae J. Clin Microbiol. 37:544-547,
1999.
156.
Rotun SS, McMath V, Schoonmaker DJ, Maupin PS, Tenover FC, Hill BC, Ackman DM: Staphylococcus aureus
with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis. 5:147-9,
1999.
157.
Garrett D, Jochimsen E, Murfitt K, Hill B, McAllister S,Nelson P, Spera R, Sall R, Tenover F, Jarvis W. The
impending apocalypse, the emergence of vancomycin resistance in Staphylococcus spp. Infect Control Hosp
Epidemiol 20:167-170, 1999.
158.
Tokars JL, Satake S, Rimland D, Carson L, Miller ER, Killum E, Sinkowitz-Cochran RL, Arduino MJ, Tenover
FC, Jarvis WR. The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans Affairs
institution. Infect Control Hosp Epidemiol 20:171-175, 1999.
159.
Fridkin SK, Edwards JR, Pichette SC, Pryor ER, McGowan JE, Tenover FC, Culver DH, Gaynes RP. Determinants
of vancomycin use in adult intensive care units in 41 United States Hospitals. Clin Infect Dis. 28:1119-1125, 1999.
160.
Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE, Archibald LK, Gaynes RP, Tenover FC, Project
ICARE hospitals: Surveillance of antimicrobial use and resistance in United States hospitals: Project ICARE Phase
II. Clin Infect Dis 29:245-252, 1999.
161.
Ostrowsky BE, Clark NC, Thauvin-Eliopoulos, Venkataraman L, Samore MH, Tenover FC, Liopoulos GM,
Moellering RC, Gold HS. A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular
characterization and clinical epidemiology. J Infect Dis 180:1177-1185, 1999.
162.
Tenover FC. Implications of vancomycin resistant Staphylococcus aureus. J. Hospital Infect. 43 (Supplement):S3S7, 1999.
163.
Dembek ZF, Kellerman SE, Ganley L, Kruiningen HV, Cartter ML, Hadler JL, Tenover FC, Jarvis W:
Implementation and validation of state-based surveillance of vancomycin resistant enterococci in Connecticut.
Infect Control Hosp. Epidemiol 20:671-675, 1999.
16
164.
Hubert SK, Mohammed JM, Fridkin SK, Gaynes RP, McGowan JE, Jr, Tenover FC: Glycopeptide-intermediate
Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals. J
Clin Microbiol. 37:3590-3593, 1999.
165.
Tenover FC, Jones RN, Swenson JM, Zimmer B, McAllister S, Jorgensen JH, for the NCCLS Staphylococcus
Working Group. Methods for improved detection of oxacillin-resistance in coagulase negative staphylococci: results
of a multicenter study. J Clin Microbiol 37:4051-4058, 1999.
166.
Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF: Detection and reporting of organisms producing extendedbeta-lactamases: a survey of laboratories in Connecticut. J Clin Microbiol 37:4065-4070, 1999.
167.
Johnson S, Samore MH, Killgore GE, Tenover FC, Farow KA, Lyras D, Rood JI, De Girolami P, Baltch AL, Pear
SM, Gerding DN. United States hospital epidemics of Clostridium difficile- associated diarrhea caused by a
clindamycin-resistant strain of C. difficile. N Engl J Med. 341:1645-1651, 1999.
168.
Rosenstein NE, Stocker SA, Popovic T, Tenover FC, Perkins BA. Resistance to antimicrobial agents among
isolates of Neisseria meningitidis from the United States, 1997. Clin Infect Dis. 30:212-213, 2000.
169.
Mohammed MJ, Tenover FC: Evaluation of the PASCO Strep Plus broth microdilution antimicrobial susceptibility
panels for testing Streptococcus pneumoniae and other Streptococcal species. J Clin Microbiol. 38:1713-1716, 2000.
170.
Fridkin SK, Edwards JR, Pichette SC, Pryor ER, McGowan JE, Tenover FC, Culver DH, Gaynes RP: The impact
of clinical practice guidelines on vancomycin use in adult intensive care units at United States hospitals. Clin Infect
Dis, 2000.
171.
Hill B, Baker CN, Tenover FC: A simplified method for testing Bordetella pertussis for resistance to erythromycin
and other antimicrobial agents. J Clin Microbiol. 38:1151-1155, 2000.
172.
Killgore GE, Holloway B, Tenover FC: A 5' nuclease PCR (Taqman) high throughput assay for detection of the
mecA gene in staphylococci. J Clin Microbiol 38:2516-2519, 2000.
173.
Rasheed JK, Ferraro MJ, Swenson JM, Biddle J, Steward C, Yigit H, Tenover FC: Characterization of the
extended-spectrum β -lactamase (ESBL) reference strain Klebsiella pneumoniae K6 (ATCC 700603), which
produces the novel enzyme SHV-18. Antimicrob Agents Chemother 44:2382-2388, 2000.
174.
Tenover FC: VRSA, VISA, GISA: The dilemma behind the name game. Clin Microbiol Newsletter. 22:49-53,
2000.
175.
Deplano A, Schuermans A, Van Eldere J, Witte W, Meugnier H, Etienne J, Grundmann H, Jonas D, Noordhoek GT,
Dijkstra J, van Belkum A, van Leeuwen W, Tassios PT, Legakis NJ, van der Zee A, Bergmans A, Blanc DS,
Tenover FC, Cookson BC, O'Neil G, Struelens MJ: Multicenter evaluation of epidemiological typing of
methicillin-resistant Staphylococcus aureus strains by repetitive-element PCR analysis. The European Study Group
on Epidemiological Markers of the ESCMID.J Clin Microbiol. 38:3527-3533, 2000.
176.
Steward CD, Wallace D, Hubert SK, Lawton R, Fridkin SK, Gaynes RP, McGowan JE, Jr, Tenover FC: Ability of
laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of Project ICARE
laboratories. Diag Microbiol Infect Dis. 38:59-67, 2000.
177.
Gay K, Baughman W, Miller Y, Jackson D, Whitney CG, Schuchat A, Farley M, Tenover F, Stephens DS: The
emergence of Streptococcus pneumoniae resistant to macrolide microbial agents: a five year population-based
assessment. J Infect Dis. 182:1417-1424, 2000.
178.
Dunne EF, Fey PD, Kludt P, Reporter R, Mostashar F, Shillam P, Wicklund J, Miller C, Holland B, Stamey K,
17
Barrett TJ, Rasheed JK, Tenover FC, Ribot EM, Angulo FJ: Emergence of domestically acquired ceftriaxoneresistant Salmonella infections associated with AmpC beta-lactamase. JAMA. 284:3151-3156, 2000.
179.
Jorgensen JH, Weigel LM, Swenson JM, Whitney CG, Ferraro MJ, Tenover FC: Activities of clinafloxacin,
gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus
pneumoniae. Antimicrob Agents Chemother. 44:2962-2968, 2000.
180.
Tenover FC, Mohammed JM, Stelling J, O’Brien TF, Williams R: Ability of laboratories to detect emerging
antimicrobial resistance: proficiency testing and quality control results from the World Health Organization’s
external quality assurance system for antimicrobial susceptibility testing. J Clin Microbiol. 39:241-250, 2001.
181.
Tenover FC, Biddle JW, Lancaster MV: Increasing resistance to vancomycin and other glycopeptides among
strains of Staphylococcus aureus. Emerging Infect Dis.7:327-332, 2001.
182.
Peterson LR, Hamilton JD, Baron EJ, Tompkins LS, Miller JM, Wilfert CM, Tenover FC, Thomson, RB, Jr.: Role
of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of
healthcare. Clin Infect Dis. 32:605-611, 2001.
183.
Yigit H, Queenan AM, Anderson GJ, Sanchez-Sanchez AD, Biddle JW, Steward CD, Alberti S, Bush K, Tenover
FC: Novel carbapenem-hydrolyzing β -lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella
pneumoniae. Antimicrob Agents Chemother. 45:1151-1161, 2001.
184.
Lee WG, Tenover FC, Rasheed JK, Anderson, GJ, Jernigan JA: Possible horizontal transfer of the vanB2 gene
among genetically diverse strains of vancomycin-resistant Enterococcus faecium in a Korean hospital. J Clin
Microbiol. 39:1165-1168, 2001.
185.
Daneshvar MI, Hollis DG, Steigerwalt AG, Whitney AM, Spangler L, Douglas MP, Jordan JG, MacGegor, Hill BC,
Tenover FC, Brenner DJ, Weyant RS: Assignment of CDC Weak Oxidizer Group 2 (WO-2) to the Genus
Pandoraea and Characterization of three new Pandoraea genomospecies. J Clin Microbiol. 39:1819-1826, 2001.
186.
Boras A, Bozinovic D, Tenover FC, Popovic T: First report of Neisseria meningitidis intermediately resistant to
penicillin in Croatia. J Clin Microbiol 39:823, 2001.
187.
Tondella ML, Rosenstein NE, Mayer LW, Tenover FC, Stocker SA, Reeves MW, Popovic T. Lack of evidence for
chloramphenicol resistance in Neisseria meningitidis. Emerg Infect Dis 7:163-164, 2001.
188.
Steward CD, Hubert SK, Biddle JW, Raney PM, Anderson GJ, Rasheed JK, Williams PP, Brittain KL, McGowan
JE, Jr, Tenover FC: Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the
National Committee for Clinical Laboratory Standards (NCCLS) extended-spectrum beta-lactamase (ESBL)
detection methods. J Clin Microbiol 39:2864-2872, 2001.
189.
McGee L, McDougal L, Zhou J, Spratt BG, Tenover FC, George R, Hakenbeck R, Hryniewicz, Lefevre JC,
Tomasz A, Klugman KP: Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae
defined by the Pneumococcal Molecular Epidemiology Network. J Clin Microbiol. 39:2665-2571, 2001.
190.
Tenover FC: Development and spread of bacterial resistance to antimicrobial agents: an overview. Clin Infect Dis.
33:S108-S115, 2001.
191.
Fridkin SK, Edwards JR, Courval JM, Hill H, Tenover FC, Lawton R, Gaynes RP, McGowan JE Jr; Intensive Care
Antimicrobial Resistance Epidemiology (ICARE) Project and the National Nosocomial Infections Surveillance
(NNIS) System Hospitals: The effect of vancomycin and third-generation cephalosporins on prevalence of
vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med. 135:175-183, 2001.
18
192.
Fridkin SK, Edwards JR, Tenover FC, Gaynes RP, McGowan JE Jr, Intensive Care Antimicrobial Resistance
Epidemiology (ICARE) Project, National Nosocomial Infections Surveillance (NNIS) System Hospitals:
Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens
associated with hospital-acquired infections. Clin Infect Dis 33:324-330, 2001.
193.
Weigel LM, Anderson GJ, Facklam RR, Tenover FC: Genetic analyses of mutations contributing to
fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother
45:3517-3523, 2001.
194.
Hageman JC, Pegues DA, Jepson C, Bell RL, Guinan M, Ward KW, Cohen MD, Hindler JA, Tenover FC,
McAllister SK, Kellum ME, Fridkin SK. Vancomycin-intermediate Staphylococcus aureus in a home healthcare
patient. Emerg Infect Dis 6:1023-1025, 2001.
195.
Tokars JI, Gehr T, Jarvis WR, Anderson J, Armistead N, Miller ER, Parrish J, Qaiyumi A, Arduino M, Holt SC,
Tenover FC, Westbrook G, Light P: Vancomycin-resistant enterococci colonization in patients at seven
hemodialysis centers. Kidney International 60:1511-1516, 2001.
196.
Swenson JM, Spargo J, Tenover FC, Ferraro MJ: Optimal inoculation methods and quality control for the NCCLS
oxacillin agar screen test for detection of oxacillin resistance in Staphylococcus aureus. J Clin Microbiol 39:37813784, 2001.
197.
Swenson JM, Williams PP, Killgore G, O’Hara CM, Tenover FC: Performance of eight methods, including two
rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus. J Clin Microbiol
39:3785-3788, 2001.
198.
Swenson JM, Tenover FC: In vitro activity of a new cephalosporin, RWJ-54428 (MC-02,479) against streptococci,
enterococci, and staphylococci, including glycopeptide-intermediate Staphylococcus aureus. J Antimicrob
Chemother. 49:845-850, 2002.
199.
Weigel LM, Anderson GJ, Tenover FC: gyrA and parC mutations associated with fluoroquinolone resistance in
Proteus mirabilis. Antimicrob Agents Chemother. 46:2582-2587, 2002.
200.
Mohammed MJ, Marston CK, Popovic T, Weyant RS, Tenover FC: Antimicrobial Susceptibility Testing of
Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory
Standards broth microdilution reference and Etest agar gradient diffusion methods. J Clin Microbiol. 40:1902-1907,
2002
201.
Fridkin SK, Lawton R, Edwards JR, Tenover FC, McGowan JE Jr, Gaynes RP: Monitoring antimicrobial use and
resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant
enterococci. Emerg Infect Dis. 8:702-707, 2002.
202.
Elliott MJ, Kellum MT, Tenover FC, Pettriess RL: Nasal carriage of methicillin-susceptible and methicillinresistant Staphylococcus aureus among paramedics in the Sedgwick County emergency medical service in Wichita,
Kansas. Infect Control Hosp Epidemiol. 23:60-61, 2002.
203.
Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, Cetron M, Cohen M, Doyle T, Fischer
M, Greene C, Griffith KS, Guarner J, Hadler JL, Hayslett JA, Meyer R, Petersen LR, Phillips M, Pinner R, Popovic
T, Quinn CP, Reefhuis J, Reissman D, Rosenstein N, Schuchat A, Shieh WJ, Siegal L, Swerdlow DL, Tenover FC,
Traeger M, Ward JW, Weisfuse I, Wiersma S, Yeskey K, Zaki S, Ashford DA, Perkins BA, Ostroff S, Hughes J,
Fleming D, Koplan JP, Gerberding JL; National Anthrax Epidemiologic Investigation Team: Investigation of
bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis. 8:1019-28, 2002.
204.
Rasheed JK, Anderson GJ, Queenan AM, Biddle JW, Oliver A, Jacoby GA, Bush K, Tenover FC: TEM-71, a
19
novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae.
Antimicrob Agents Chemother. 46:2000-2003, 2002.
205.
Yigit H, Anderson GJ, Biddle JW, Steward CS, Valera L, Tenover FC: Imipenem resistance in a clinical isolate of
Enterobacter aerogenes is associated with decreased expression of the OmpF and OmpC porin analogs. Antimicrob
Agents Chemother 46:3817-3822, 2002.
206.
McGowan JE, Jr, Hill HA, Volkova NV, Lawton RM, Haber MJ, Tenover FC, Gaynes RP, and ICARE Project
Hospitals: Does antimicrobial resistance cluster in individual hospitals? J Infect Dis 186:1362-1365, 2002.
207.
Oliver A, Weigel LM, Rasheed JK, McGowan JE Jr, Tenover FC: Mechanisms of decreased susceptibility to
cefpodoxime in Escherichia coli. Antimicrob Agents Chemother. 46:3829-3836, 2002.
208.
Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O'Brien FG, Coombs GW, Pearman JW, Tenover FC,
Kapi M, Tiensasitorn C, Ito T, Hiramatsu K: Dissemination of new methicillin-resistant Staphylococcus aureus
clones in the community. J Clin Microbiol 40:4289-4294, 2002
209.
Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy M-C, El Solh N, Ferraz
V, Hiramatsu K: Cell-wall thickening is the common feature of vancomycin resistance in Staphylococcus aureus. J
Clin Microbiol 41:5-14, 2003.
210.
Steward CD, Mohammed JM, Swenson JM, Stocker SA, Williams PP, Gaynes RP, McGowan JE Jr, Tenover FC:
Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five
antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates. J
Clin Microbiol 41:351-358, 2003.
211.
Chen Y, Succi J, Tenover FC, Koehler T: -lactamase Genes of the penicillin-susceptible Bacillus anthracis Sterne
Strain. J Bacteriol 185:823-830, 2003.
212.
Butler JC, Lennox JL, McDougal LK, Sutcliffe JA, Tait-Kamradt A, Tenover FC: Macrolide-resistant
pneumococcal endocarditis and epidural abscess that develop during erythromycin therapy. 36:e19-25, 2003.
213.
Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC: VancomycinIntermediate Staphylococcus aureus Epidemiology Study Group: Epidemiological and microbiological
characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United
States, 1997-2001. Clin Infect Dis. 36:429-39, 2003.
214.
Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown
WJ, Cardo D, Fridkin SK, Vancomycin-resistant Staphylococcus aureus investigative team: Infection with
vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 348:1342-1347,
2003.
215.
Chaitram JM, Lary S, Jevitt L, Tenover FC, WHO Antimicrobial Resistance Group: The WHO-EQAS Proficiency
Testing Program Has Improved the Accuracy of Antimicrobial Susceptibility Testing and Reporting Among
Participating Laboratories Using NCCLS Methods. J Clin Microbiol 41:2372-2377, 2003.
216.
Tenover FC, Raney PM, Williams PP, Rasheed JK, Biddle JW, Oliver A, Fridkin SK, Jevitt L, McGowan JE Jr:
Evaluation of the NCCLS extended-spectrum beta-lactamase (ESBL) confirmation methods for Escherichia coli
using isolates collected during Project ICARE. J. Clin Microbiol 41:3142-3146, 2003.
217.
Duck WM, Steward CD, Banerjee SN, McGowan JE Jr., Tenover FC: Optimization of computer software settings
improves analysis of pulsed-field gel electrophoresis macrorestriction fragment patterns. J Clin Microbiol. 41:30353042, 2003.
20
218.
Naimi TS, Anderson D, O’Boyle C, Boxrud DJ, Johnson SK, Tenover FC, Lynfield R: Vancomycin-intermediate
Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia. Clin
Infect Dis. 36:1609-1612, 2003.
219.
Paule SM, Trick WE, Tenover FC, Lankford M, Cunningham S, Stosor V, Cordell RL, Peterson LR: Comparison of
polymerase chain reaction to culture for surveillance detection of vancomycin-resistant enterococci. J Clin
Microbiol. 41:4805-4807, 2003.
220.
Stevenson KB, Samore M, Barbera J, Moore JW, Hannah E, Houck P, Tenover FC, Gerberding JL: Detection of
antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with
current NCCLS laboratory standards. Diag Microbiol Infect Dis. 47:303-311, 2003.
221.
Yigit H, Queenan AM, Anderson GA, Biddle JW, Steward CD, Domenech-Sanchez A, Alberti S, McGowan JE,
Bush K, Tenover FC: Characterization of a carbapenem-resistant strain of Klebsiella oxytoca harboring the KPC-2
carbapenemase. Antimicrob Agents Chemother 47:3881-3889, 2003.
222.
McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC: Pulsed-field gel
electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a
national database. J Clin Microbiol 41:5113-5120, 2003.
223.
Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan S, Killgore G, Tenover FC: Molecular
analysis of the first clinical isolate of vancomycin-resistant Staphylococcus aureus. Science 302:1569-1571, 2003.
224.
Jevitt LA, Smith AJ, Williams PP, Raney PM, McGowan JE Jr, Tenover FC: In Vitro activities of daptomycin,
linezolid, and quinupristin-dalfopristin against a challenge panel of staphylococci and enterococci, including
vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Microbial Drug
Resist. 9:298-306, 2003.
225.
Schwaber MJ, Raney PM, Rasheed JK, Biddle JW, Williams P, McGowan JE, Jr, Tenover FC: Utility of the
NCCLS guidelines for identifying extended-spectrum β-lactamases in non-Escherichia coli and non-Klebesiella spp.
of Enterobacteriaceae. J Clin Microbiol 42:294-298, 2004.
226.
Tenover FC, Weigel LM, Appelbaum PC, McDougal LK, Chaitram J, McAllister S, Clark N, Killgore G, O’Hara
CM, Jevitt L, Patel JB, Bozdogan B: Characterization of a vancomycin-resistant clinical isolate of Staphylococcus
aureus from Pennsylvania. Antimicrob Agents Chemother. 48:275-280, 2004.
227.
Gaynes R, Rimland D, Killum E, Lowery HK, Johnson T, Killgore G, Tenover FC: Outbreak of Clostridium
difficile infections in a long-term nursing facility: association with gatifloxacin use. Clin Infect Dis. 38:640-645,
2004.
228.
Kaye KS, Gold H, Schwaber MJ, Venkataraman L, Qi Y, DeGirolami P, Samore MH, Anderson G, Rasheed JK,
Tenover FC: Variety of β-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the
northeastern United States. Antimicrob Agents Chemother. 48:1520-1525, 2004.
229.
Severin A, Tabei K, Tenover FC, Chung M, Clark N, Tomasz T: High-level oxacillin and vancomycin resistance
and altered cell wall composition in a strain of Staphylococcus aureus carrying both the staphylococcal mecA gene
and the enterococcal vanA gene complex. J Biol Chem. 279:3398-3407, 2004.
230.
Whitener CJ, Park SY, Browne FA, Parent LJ, Julian K, Bozdogan B, Appelbaum PC, Chaitram J, Weigel LM,
Jernigan J, McDougal LK, Tenover FC, Fridkin SK: Vancomycin-Resistant Staphylococcus aureus in the Absence
of Vancomycin Exposure . Clin Infect Dis. 38:1049-1055, 2004.
21
231.
McGowan JE, Tenover FC: Confronting bacterial resistance in healthcare settings: a crucial role for
microbiologists. Nat Rev Microbiol. 2:251-258, 2004.
232.
Buckingham SC, McDougal LK, Cathey L, Comeaux K, Brown M, Craig AS, Fridkin SK, Tenover FC: Emergence
of community-associated methicillin-resistant Staphylococcus aureus in Memphis children. Pediatr Infect Dis J.
23:619-624, 2004.
233.
Diekema DJ, Lee K, Raney P, Herwaldt LA, Doern GV, Tenover FC: Accuracy and appropriateness of
antimicrobial susceptibility test reporting for bacteria isolated from blood cultures. J Clin Microbiol. 42:2258-2260,
2004.
234.
Woods CW, Cheng AC, Fowler VG Jr, Moorefield M, Frederick J, Sakoulas G, Meka VG, Tenover FC, Zwadyk P,
Wilson KH: Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. Clin Infect
Dis. 38:1188-1191, 2004.
235.
Swenson JM, Killgore GM, Tenover FC: Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS
broth microdilution and disk diffusion methods. J Clin Microbiol 42:5102-5108, 2004.
236.
Tenover FC, Pearson ML. Methicillin-resistant Staphylococcus aureus. Emerg Infect Dis. 10:2052-2053, 2004.
237.
Chen Y, Tenover FC, Koehler TM: β-lactamase gene expression in a penicillin-resistant Bacillus anthracis strain.
Antimicrob Agents Chemother. 48:4873-4877, 2004.
238.
Dunman P, Mounts W, McAleese F, Immermann F, Macapagal D, Marsilio E, McDougal L, Tenover FC, Bradford
PA, Petersen PJ, Projan SJ, and Murphy E. Uses of Staphylococcus aureus GeneChips in genotyping and genetic
composition analysis. J Clin Microbiol. 42: 4275-4283, 2004.
239.
Clark NC, Weigel LM, Patel JB, Tenover FC: Comparison of Tn1546-like elements in vancomycin-resistant
Staphylococcus aureus isolates from Michigan and Pennsylvania. Antimicrob Agents Chemother. 49:470-472,
2005.
240.
Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, Garfinkel B, Boo T, McAllister S, Anderson J,
Jensen B, Dodson D, Lonsway D, McDougal L, Arduino M, Fraser VJ, Killgore G, Tenover FC, Cody S, Jernigan
DB. A Clone of Methicillin-Resistant Staphylococcus aureus among professional football players. N Engl J Med
352:468-75, 2005.
241.
Welsh KJ, Barlow M, Tenover FC, Biddle JW, Rasheed JK, Clark LA, McGowan JE Jr. Experimental Prediction of
the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase. Antimicrob Agents
Chemother. 49:1242-1244, 2005.
242.
Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Edwards G, O'Brien FG, Tenover FC,
McDougal LK, Monk AB, and Enright MC: Re-emergence of early pandemic Staphylococcus aureus as a
community-acquired meticillin-resistant clone. Lancet. 365:1256-8, 2005.
243.
Steward CD, Raney PM, Morrell AK, Williams PP, McDougal LK, Jevitt L ,McGowan JE Jr, Tenover FC: Testing
for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus J Clin
Microbiol. 43:1716-21, 2005.
244.
Tenover FC: The real vancomycin-resistant Staphylococcus aureus has arrived. Clin Microbiol Newletter. 27:3540, 2005.
245.
Sejvar JJ, Tenover FC, Stephens, DS: Management of anthrax meningitis. Lancet Infect Dis. 5:287-95, 2005.
22
246.
Zelazny AM, Ferraro MJ, Glennen A, Hindler JF, Mann LM, Munro S, Murray PR, Reller LB, Tenover FC,
Jorgensen JH. Selection of strains for quality assessment of the disk induction method for detection of inducible
clindamycin resistance in staphylococci: a CLSI collaborative study. J Clin Microbiol.43:2613-2615, 2005.
247.
Hidron AI, Kourbatova EV, Halvosa JS, Terrell BJ, McDougal LK, Tenover FC, Blumberg HM, King MD. Risk
factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban
hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis. 41:159-166, 2005.
248.
Tenover FC, McDonald, LC. Vancomycin-resistant staphylococci and enterococci: epidemiology and control. Curr
Opin Infect Dis. 18:300-305, 2005.
249.
Hujer KM, Hamza NS, Hujer AM, Perez F, Helfand MS, Bethel CR, Thomson JM, Anderson VE, Barlow M, Rice
LB, Tenover FC, and Bonomo RA: Identification of a new allelic variant of the Acinetobacter baumannii
cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes. Antimicrob Agents
Chemother. 49:2941-2948, 2005.
250.
Swenson JM, Tenover FC: Prediction of mecA-mediated resistance in Staphylococcus spp. using a disk diffusion
method with cefoxitin. J Clin Microbiol. 43:3818-3823, 2005.
251.
Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan GA, McAllister SK, Fosheim G, McDougal LK, Chaitram J,
Jensen B, Fridkin SK, Killgore G, Tenover FC: Prevalence of Staphylococcus aureus Nasal Colonization in the
United States. J Infect Dis. 193:172-179, 2006
252.
Tenover FC, McDougal LK, Goering RV, Killgore G, Projan S, Patel JB, Dunman PM: Characterization of a
widely disseminated strain of community-associated methicillin-resistant Staphylococcus aureus from the United
States. J Clin Microbiol 44:108-118, 2006.
253.
Klevens RM, Edwards JR, Tenover FC, McDonald, LC, Horan T, Gaynes R. Changes in the epidemiology of
oxacillion (methicillin)-resistant Staphylococcus aureus (ORSA) in intensive care units in United States Hospitals:
1992-2003. Clin Infect Dis. 42:389-391, 2006.
254.
Aires-de-Sousa M, Boye K, de Lencastre H, Deplano A, Enright MC, Etienne J, Friedrich A, Harmsen D, Holmes A,
Huijsdens XW, Kearns AM, Mellman A, Meugnier H, Rasheed JK, Spalburg E, Strommenger B, Struelens MJ,
Tenover FC, Thomas J, Vogel U, Westh H, Xu J, and Witte W. High interlaboratory reproducibility of DNA
sequence-based typing of bacteria in a multicenter study. J Clin Microbiol. 44:619-621, 2006.
255.
Rao A, Tenover FC, Boring J, McGowan JE, Jr.: Class I integron carriage is highly prevalent among antimicrobial
resistant isolates of Escherichia coli and Klebsiella species from U.S. hospitals. Emerg Infect Dis 12:1011-1014,
2006
256.
Tenover FC: Mechanisms of antimicrobial resistance in bacteria. Am J Med.119 (6 Suppl 1):S3-10, 2006.
257.
Hageman JC, Liedtke LA, Sunenshine RH, Strausbaugh LJ, McDonald LC, Tenover FC, and the Infectious
Diseases Society of America Emerging Infections Network. Management of persistent bacteremia caused by
methicillin-resistant Staphylococcus aureus: a survey of infectious diseases consultants. Clin Infect Dis. 43(5):e4245, 2006.
258.
Jorgensen JH, Crawford SA, Fulcher LC, Glennen A, Harrington SM, Swenson J, Lynfield R, Murray PR, Tenover
FC. Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis
isolates. J Clin Microbiol. 44:1744-1754, 2006.
259.
Tenover FC, Kalsi RK, Williams PP, Carey RB, Stocker S, Lonsway D, Rasheed JK, Biddle JW, McGowan JE, Jr.,
Hanna B. Failure of automated susceptibility testing systems to detect carbapenem resistance in Klebsiella
23
pneumoniae Mediated by KPC Beta-lactamases. Emerg Infect Dis 12:1209-1213, 2006.
260.
Tenover FC: Community-associated methicillin-resistant Staphylococcus aureus: It’s not just in communities
anymore. Clin Microbiol Newsletter 28:33-36, 2006.
261.
Jevitt LA, Thorne GM, Traczewski MM, Jones RN, McGowan JE, Jr., Tenover FC, Brown SD. Multicenter
evaluation of the Etest and disk diffusion methods for assessing daptomycin non-susceptibility among
Staphylococcus aureus isolates. J Clin Microbiol 44:3098-3104, 2006.
262.
Zhu W, Tenover FC, Limor J, Lonsway D, Jackson MA, Black P, Dunne WM, Patel JB. A point mutation in the
Domain V of 23S rRNA contributes to the linezolid resistance in Staphylococcus aureus. European J Clin Microbiol
Infect. 26:161-165, 2007.
263.
Klevens RM, Morrison MA, Fridkin SK, Reingold A, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R,
Dumyati G, Townes JM, Craig AS, Fosheim G, McDougal LK, Tenover FC, Active Bacterial Core surveillance of
the Emerging Infections Program Network. Spread of community-associated methicillin-resistant Staphylococcus
aureus (MRSA) strains in healthcare settings. Emerg Infect Dis. 12:1991-1993, 2006.
264.
Bonnstetter KK, Wolter DJ, Tenover FC, McDougal LK, Goering RV. Rapid multiplex PCR assay for identification
of USA300 Community-Associated Methicillin-Resistant Staphylococcus aureus isolates. J Clin Microbiol. 45:141146, 2007.
265.
Stone ND, O’Hara CM, Williams PP, McGowan EJ, Jr, Tenover FC: Comparison of Disk Diffusion, VITEK 2, and
broth microdilution antimicrobial susceptibility testing results for unusual species of Enterobacteriaceae. J Clin
Microbiol 45:340-346, 2007.
266.
Tenover FC: Rapid detection and identification of bacterial pathogens using novel molecular technologies:
infection control and beyond. Clin Infect Dis. 44:418-423, 2007.
267.
Tenover FC, Moellering RC, Jr. The rationale for revising the Clinical and Laboratory Standards Institute
vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis.
44:1208-1215, 2007.
268.
Tenover FC, Vaughn RR, McDougal LK, Fosheim GE, McGowan JE, Jr. Multiple locus variable number tandem
repeat assay analysis of methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol. 45:2215-2219, 2007.
269.
Goering RV, McDougal LK, Fosheim GE, Bonnstetter KK, Wolter DJ, Tenover FC: Epidemiologic distribution of
the arginine catabolic mobile element (ACME) among selected methicillin-resistant and methicillin-susceptible
Staphylococcus aureus isolates. J Clin Microbiol 45:1981-1984, 2007.
270.
Wolter DJ, Tenover FC, Goering RV. Allelic Variation in genes encoding Panton-Valentine Leukocidin from
community-associated Staphylococcus aureus. Clin Microbiol Infect. 13:827-830, 2007.
271.
Counts JM, Astles, JR, Tenover FC, Hindler J: A systems approach to improving antimicrobial susceptibility testing
in clinical laboratories in the United States. J Clin Microbiol. 45:2230-2234, 2007.
272.
Tenover FC, Williams PP, Stocker S, Thompson A, Clark LA, Limbago B, Carey R, Poppe SM, Shinabarger D,
McGowan, JE Jr. Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci
and enterococci. J Clin Microbiol 45:2917-2922, 2007.
273.
Srinivasan V, Tenover FC, McAllister S, McGowan JE, Jr: In vitro activity of ceftobiprole against coagulasenegative staphylococci isolated in the United States. International J Antimicrob Agents. 31:294-296, 2008.
24
274.
Kennedy AD, Otto M, Braughton KR, Whitney AR, Chen L, Mathema B, Mediavilla J, Byrne KA, Parkins LD,
Tenover FC, Kreiswirth BD, Musser JM, DeLeo FR: Epidemic community-associated methicillin-resistant
Staphylococcus aureus: Recent clonal expansion and diversification. Proc Natl Acad Sci (USA) 105:1327-1332,
2008.
275.
Melles DC, Tenover FC, Kuehnert MJ, Witsenboer H, Peeters JK, Verbrugh HA, van Belkum A: Overlapping
population structures of nasal isolates of Staphylococcus aureus from healthy Dutch and American individuals. J
Clin Microbiol. 46:235-241, 2008.
276.
Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan GM, McDougal LK, Fosheim GE, Jensen BJ, Killgore
G, Tenover FC, Kuehnert MJ: Changes in Staphylococcus aureus nasal colonization in the United States, 20012004. J Infect Dis. 197:1226-34, 2008.
277.
Barlow M, Reik RA, Jacobs SD, Medina M, Meyer MP, McGowan JE, Jr., Tenover FC: High rate of mobilization
for blaCTX-Ms Emerg Infect Dis. 14:423-428, 2008.
278.
Diep BA, Chambers HF, Graber CJ, Szumowski JD, Miller LG, Han LL, Chen JH, Lin F, Lin J, Phan THV,
Carleton HA, McDougal LK, Tenover FC, Cohen DE, Mayer KH, Sensabaugh GF, Crim D, Perdreau-Remington
F : Emergence of multidrug-resistant community-associated methicillin-resistant Staphylococcus aureus clone
USA300 in men who have sex with men. Annals Intern Med. 148:249-257, 2008.
279.
Tenover FC: Vancomycin-resistant Staphylococcus aureus: a perfect but geographically limited storm? Clin Infect
Dis. 46:675-676, 2008.
280.
Endimiani A, Carias LL, Hujer AM, Bethel CR, Hujer KM, Perez F, Hutton RA, Fox WR, Hall GS, Jacobs MR,
Paterson DL, Rice LB, Jenkins SG, Tenover FC, and Bonomo RA: Presence of plasmid-mediated quinolone
resistance in Klebsiella pneumoniae possessing blaKPC in the United States. Antimicrob Agents Chemother 52:26802682, 2008.
281.
Tenover FC, McAllister S, Fosheim G, McDougal LK, Carey RB, Limbago B, Patel JB, Kuehnert M, Gorwitz R.
Characterization of Staphylococcus aureus isolates from nasal cultures of individuals in the United States, 20012004. J Clin Microbiol 46:2837-2841, 2008.
282.
Reik R, Tenover FC, Klein E, McDonald LC. The burden of vancomycin-resistant enterococcal infections in US
hospitals, 2003 to 2004. Diagn Microbiol Infect Dis. 62:81-85, 2008.
283.
Tenover FC, Emery SL, Spiegel CA, Bradford PA, Eells S, Endimiani A, Bonomo RA, McGowan JE Jr;
Identification of plasmid-mediated AmpC beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus
species can potentially improve reporting of susceptibility testing results. J Clin Microbiol 47:294-299, 2009.
284.
Endimiani A, Hujer AM, Perez F, Bethel CR, Hujer KM, Kroeger J, Oethinger M, Paterson DL, Adams MD, Jacobs
MR, Diekema DJ, Hall GS, Jenkins SG, Rice LB, Tenover FC, Bonomo RA: Characterization of blaKPC-containing
Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother.
63:427-437, 2009.
285.
Goering RV, Larsen AR, Skov R, Tenover FC, Anderson KL, Dunman PM: Comparative genomic analysis of
European and Middle Eastern community-associated methicillin-resistant Staphylococcus aureus (CC80:T80-IV)
isolates by high density microarray. Clin Microbiol Infect 15:748-755, 2009.
286.
Tenover FC, Sinner SF, Segal RE, Huang V, Alexandre S, McGowan JE, Jr., Weinstein M;
Characterization of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and
daptomycin during therapy. International J Antimicrob Chemother. 33:564-568, 2009.
25
287.
Swenson JM, Anderson KF, Lonsway DR, Thompson A, McAllister SK, Limbago BM, Carey RB, Tenover FC,
Patel JB. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycinintermediate Staphylococcus aureus. J Clin Microbiol. 47:2013-2017, 2009.
288.
Lessa FC, Edwards JR, Fridkin SK, Tenover FC, Horan C Gorwitz RJ. Trends I incidence of late-onset, methicillinresistant Staphylococcus aureus infection in neonatal intensive care units: data from the national nosocomial
infections surveillance system, 1995-2004 Pediatric Infect Dis J 28:577-581, 2009.
289.
Tenover FC, Gay EA, Frye S, Eells SJ, Healy M, McGowan JE Jr.: Comparison of typing results obtained for
methicillin-resistant Staphylococcus aureus isolates with the DiversiLab system and pulsed-field gel electrophoresis.
J Clin Microbiol 47:2452-2457, 2009.
290.
Tenover FC, Goering RV: Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J
Antimicrob Chemother 64:441-446, 2009.
291.
International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC)
Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec
elements. Antimicrobial Agents Chemother 53:4961-4967, 2009.
292.
Endimiani A, Depasquale JM, Forero S, Perez F, Hujer AM, Robeerts-Pollack D, Fiorella PD, Pickens N, Kitchel B,
Casiano-Colon AE, Tenover FC, Bonomo RA: Emergence of blaKPC-containing Klebsiella pneumoniae in a long
term care hospital: a new challenge to our healthcare system. J Antimicrob Chemother. 64:1102-1110, 2009.
293.
Mermel LA, Eells SJ, Acharya MK, Cartony JM, Dacus D, Fadem S, Gay EA, Gordon S, Lonks JR, Perl TM,
McDougal LK, McGowan JE, Maxey G, Morse D, Tenover FC: Quantitative analysis of methicillin-resistant
Staphylococcus aureus (MRSA) nasal colonization in different patient populations: A prospective, multi-centered
study. Infect Control Hosp Epidemiol. 31(6):592-597, 2010.
294.
Tenover FC, Novak-Weekley S, Woods CW, Peterson LR, Davis T, Schreckenberger P, Fang FC, Dascal A,
Gerding DA, Nomura JH, Goering RV, Akerlund T, Weissfeld AS, Baron EJ, Wong E, Marlowe EM, Whitmore J
Persing DH: Impact of strain types on detection of toxigenic Clostridium difficile: Comparison of molecular
diagnostic and enzyme immunoassay approaches. J Clin Microbiol. 48:3719-3724, 2010.
295.
Tenover FC: The quest to identify heterogeneously resistant – vancomycin intermediate Staphylococcus aureus
strains. Int J Antimicrob Agents. 36:303-306, 2010.
296.
Tenover FC: Potential impact of rapid diagnostic tests on improving antimicrobial use. Ann N Y Acad Sci.
1213:70-80, 2010.
297.
Tenover FC: Developing molecular amplification methods for rapid diagnosis of respiratory tract infections caused
by bacterial pathogens. Clin Infect Dis. 2011. 52 Suppl 4:S338-45.
298.
Kennedy AD, Porcella SF, Martens C, Whitney AR, Braughton KR, Chen L, Craig CT, Tenover FC, Kreiswirth
BN, Musser JM, DeLeo FR: Complete nucleotide sequence analysis of plasmids in strains of Staphylococcus aureus
clone USA300 reveals a high level of identity among isolates with closely related core genome sequences. J Clin
Microbiol. 48:4504-4511, 2010.
299.
Harbarth S, Hawkey PM, Tenover F, Stefani S, Pantosti A, Struelens MJ: Update on screening and clinical
diagnosis of meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents. 37:110-117, 2011
26
300.
301.
Tenover FC, Åkerlund T, Gerding DN, Goering RV, Bolström T, Jonsson AM, Wong E, Wortman AT,
Persing DH: Comparison of strain typing results for Clostridium difficile isolates from North America. J
Clin Microbiol. 49:1831-1837, 2011.
Tenover FC, Tickler I, Armstrong ES, Kubo A, Lopez S, Persing DH, and Miller GH: Activity of ACHN-490
Against Methicillin-resistant Staphylococcus aureus Isolates from Patients in U.S. Hospitals. International J
Antimicrob Agents. 38(4):352-354, 2011.
302.
Infectious Diseases Society of America (IDSA), Spellberg B, Blaser M, Guidos RJ, Boucher HW, Bradley JS,
Eisenstein BI, Gerding D, Lynfield R, Reller LB, Rex J, Schwartz D, Septimus E, Tenover FC, Gilbert DN:
Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis. 52 Suppl 5:S397-428,
2011.
303.
Tenover FC, Baron EJ, Peterson LR, Persing DH: Laboratory diagnosis of Clostridium difficile infection: Can
molecular amplification methods move us out of uncertainty? J Mol Diag. 13:573-582, 2011.
304.
Tenover FC, Tickler IA, Goering RV, Kreiswirth BN, Mediavilla JR, Persing H, for the MRSA Consortium:
Characterization of nares and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in
United States hospitals. Antimicrobial Agents Chemother. 56:1324-1330, 2012.
305.
Tenover FC, Tickler IA, Persing H: Antimicrobial resistant strains of Clostridium difficile from North America.
Antimicrobial Agents Chemother. 56:2929-2932, 2012.
306.
Baron EJ, Tenover FC: Methicillin-resistant Staphylococcus aureus diagnostics: state of the art. Expert Opin Med
Diagn. 6:585-592, 2012.
307.
Ito T, Hiramatsu K, Tomasz A, de Lencastre H, Perreten V, Holden MTG, Coleman DC, Goering R, Giffard PM,
Skov RL, Zhang K, Westh H, O’Brien F, Tenover FC, Oliveira DC, Boyle-Vavra S, Laurent F, Kearns AM,
Kreiswirth B, Ko KS, Grundmann H, Sollid JE, John JF, Jr. Daum R, Soderquist B, Buist G, on behalf of the
International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC):
Guidelines for Reporting Novel mecA Gene Homologues. Antimicrob Agents Chemother . 56:4997-4999, 2012.
308.
Stone ND, Lewis DR, Johnson TM 2nd, Hartney T, Chandler D, Byrd-Sellers J, McGowan JE Jr, Tenover FC,
Jernigan JA, Gaynes RP; Southeast Veterans Affairs Long-Term Care Methicillin-Resistant Staphylococcus aureus
Cooperative: Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage in residents of Veterans Affairs
long-term care facilities: role of antimicrobial exposure and MRSA acquisition. Infect Control Hosp Epidemiol.
33:551-557, 2012.
309.
Goff DA, Jankowski C, Tenover FC: Using rapid diagnostic tests to optimize antimicrobial selection in
antimicrobial stewardship programs. Pharmacotherapy. 32:677-687, 2012.
310.
Penn C, Moddrell1 C, Tickler IA, Henthorne MA, Kehrli M, Goering RV, Tenover FC: Wound infections caused
by inducible methicillin-resistant Staphylococcus aureus strains. J Global Antimicrob Resist. 1:79-83, 2013.
311.
Sharn CR, Tenover FC, Goering RV: Transduction of Staphylococcal Cassette Chromosome mec Elements
Between Strains of Staphylococcus aureus. Antimicrob Agents Chemother. 57:5233-5238, 2013.
312.
Tenover FC, Canton R, Kop JA, Chan R, Ryan J, Weir F, Ruiz-Garbajosa P, LaBombardi V, Persing DH:
Detection of patients colonized with carbapenemase-producing gram-negative bacilli using the Xpert MDRO assay.
J Clin Microbiol. 50;4017-4120, 2013.
313.
Caliendo AM, Gilbert DN, Ginocchio CC, Hanson KE, May L, Quinn TC, Tenover FC, Alland D, Blaschke AJ,
Bonomo RA, Carroll KC, Ferraro MJ, Hirschhorn LR, Joseph WP, Karchmer T, MacIntyre AT, Reller LB, Jackson
27
AF: Infectious Diseases Society of America. Better tests, better care: improved diagnostics for infectious diseases.
Clin Infect Dis. 57 Suppl 3:S139-170, 2013.
314.
Green DA, Srinivas N, Watz N, Tenover FC, Amieva M, Banaei N: A pediatric case of New Delhi metallo-βlactamase-1-producing Enterobacteriaceae in the United States. Pediatr Infect Dis J. 32:1291-1294, 2013.
315.
Kaiser RM, Castanheira M, Jones RN, Tenover F, Lynfield R: Trends in Klebsiella pneumoniae carbapenemase
positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program.
Diagn Microbiol Infect Dis. 76:356-360, 2013.
316.
Tickler IA, Goering RV, Whitmore JD, Lynn AN, Persing DH, Tenover FC; Healthcare Associated Infection
Consortium: Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United
States, 2011 to 2013. Antimicrob Agents Chemother. 58:4214-8, 2014.
317.
Tenover FC, Tickler, IA: Is that Staphylococcus aureus isolate really methicillin-susceptible? Clin Microbiol.
Newsletter. 37:79-84, 2015.
Book Chapters
1.
Tenover FC, Clark VL, and Young FE: Plasmid specific proteins from Neisseria gonorrhoeae. pp. 181-183. In
Genetics and Immunobiology of Pathogenic Neisseria. D. Danielson and S. Normark (eds), University of Umea,
Umea, Sweden, 1981.
2.
Clark VL, Tenover FC, and Young FE: Development of a DNA-directed in-vitro protein synthesis system in
Neisseria gonorrhoeae. pp. 145-148. In Genetics and Immunobiology of Pathogenic Neisseria. D. Danielson and
S. Normark (eds), University of Umea, Umea, Sweden, 1981.
3.
Young FE, Clark VL, and Tenover FC: Biochemical genetics of pathogenicity of Neisseria gonorrhoeae. pp. 131134. In Genetics and Immunobiology of Pathogenic Neisseria. D. Danielson and S. Normark (eds), University of
Umea, Umea, Sweden, 1981.
4.
Tenover FC, and Plorde JJ: DNA probes for epidemiological studies of aminoglycoside resistant bacteria. pp.125128. Microbiology-1986. D. Schlessinger (ed), American Society for Microbiology, Washington, DC, 1986.
5.
Tenover FC, Williams S, and Plorde JJ: Conjugal transfer of plasmids between Campylobacter jejuni and
Campylobacter coli. pp. 47-50. In Campylobacter III. AD Pearson, MB Skirrow, H Lior and B Rowe (eds). Public
Health Laboratory Service, London, 1985.
6.
Tenover FC: DNA probes for antimicrobial resistance genes. pp. 149-152. In DNA Probes; Applications in
Genetic and Infectious Diseases and Cancer. LS Lerman (ed), Cold Spring Harbor Press, Cold Spring Harbor, 1986.
7.
Tenover FC: Constructing DNA probes for infectious agents. pp. 1-13. In DNA Probes for Infectious Diseases.
FC Tenover (ed), CRC Press, Inc. Boca Raton, LA, 1988.
8.
Tenover FC: Impact of DNA probes on clinical microbiology. pp. 31-41. In DNA Probes for Infectious Diseases.
FC Tenover (ed), CRC Press, Inc., Boca Raton, 1988
9.
Tenover FC: Probes for bacterial stool pathogens. pp. 453-63. In DNA probes for Infectious Diseases. FC
Tenover (ed) CRC Press, Inc., Boca Raton, 1988.
10.
Tenover FC: Use of probes for antimicrobial susceptibility studies. pp. 259-268. In DNA Probes for Infectious
Diseases. FC Tenover (ed), CRC Press, Inc., Boca Raton, 1988.
11.
Tenover FC and Fennell CL: The Genera Campylobacter and Helicobacter. pp. 3488-3511 In The Prokaryotes.
Springer-Verlag, Berlin, 1992.
12.
Tenover FC: Diagnosis of bacterial infections. In Encyclopedia of Human Biology. Academic Press, San Diego,
28
1992.
13.
Tenover FC: Molecular methods for the clinical microbiology laboratory. pp. 119-127. In Manual of Clinical
Microbiology, 5th ed. American Society for Microbiology, Washington, DC., 1991.
14.
Tenover FC: Introduction to molecular biology. pp 10.1-10.15. In Clinical Microbiology Procedures Handbook.
Isenberg, H. (ed) American Society for Microbiology, Washington, D.C. 1993.
15.
Tenover FC, Phillips K, and Carlson LC: Plasmid electrophoresis. pp 10.2.1-10.2.6. In Clinical Microbiology
Procedures Handbook. Isenberg, H. (ed). American Society for Microbiology, Washington, DC. 1993.
16.
Tenover FC, Phillips K, and Carlson LC: Agarose gel electrophoresis. pp 10.4.1-10.4.4. In Clinical Microbiology
Procedures Handbook. Isenberg, H. (ed). American Society for Microbiology, Washington, DC. 1993.
17.
Tenover FC and Unger ER: DNA probes for infectious diseases. pp 3-25, 1993. In Diagnostic Molecular
Microbiology. DH Persing, T Smith, FC Tenover, and T White (eds). American Society for Microbiology,
Washington, D.C. 1993.
18.
Tenover FC: Diagnostic nucleic acid probes for infectious agents. pp 1305-1312. In Clinical Laboratory Medicine.
KD McClatchey (ed). Williams and Wilkins, Baltimore 1994.
19.
Tenover FC, T. Popovic, and Ø. Olsvik: Genetic methods for detecting antibacterial resistance genes. pp.13681378. In Manual of Clinical Microbiology 6th Ed. P. Murray, E. S. Baron, M. Pfaller, F. C. Tenover, R. Yolken
(eds). American Society for Microbiology, Washington, D.C. 1995.
20.
Tenover FC: Diagnosis of bacterial infections. In Encyclopedia of Human Biology. Academic Press, San Diego,
1996.
21.
Tenover FC, McGowan, JE, Jr: Bacterial resistance to antimicrobial agents. In Bacterial Infection in Humans, P
Brachman, A Evans (eds). Lippincott-Raven Publishers, New York,1998.
22.
Tenover FC, DR Schaberg: Molecular biology of resistance. Pp237-248 In Hospital Infections,4th Ed., PS
Brachman, JV Bennett (eds). Lippencott-Raven Publishers, New York, 1998.
23.
Tenover FC, Gaynes RP: Dissemination of vancomycin-resistant enterococci in the United States. Pp. 101-110.
Maurice Rapin Colloquium Medecine-Sciences Flammarion, Paris, 1998.
24.
Tenover FC: Diagnosis of bacterial infections. In Encyclopedia of Human Biology. Academic Press, San Diego,
1998.
25.
Tenover FC: Specimen management and rapid detection of infectious agents. In Clinical Infectious Diseases: a
practical approach. RK Root (ed). Oxford University Press, New York. 1999.
26.
Tenover FC, Rasheed JK: Genetic methods for detecting antimicrobial resistance genes. In Manual of Clinical
Microbiology 7th Ed. P Murray, ES Baron, MA Pfaller, FC Tenover, R Yolken (eds). American Society for
Microbiology, Washington, D.C. 1999.
27.
Gerberding JL, McGowan JE, JR, Tenover FC: Emerging nosocomial infections and antimicrobial resistance. In
Current clinical topics in infectious diseases. JS Remington, MN Schwartz (eds). Blackwell Sciences, Malden MA,
1999.
28.
Tenover FC, Gaynes RP: The epidemiology of staphylococcus infections. In Gram-Positive Pathogens. Fischetti
VA, Novick RP, Ferretti, Portnoy DA, Rood JI (eds). ASM Press, Washington, DC, 2000.
29.
Tenover FC, Mohammed MJ: Elección de un método para la vigilancia de bacterias resistentes a los
antimicrobianos. In Resistencia antimicrobiana en las Américas: Magnitud del problema y su contención.
Salvatierra-González R, Benguigui Y (eds). Organización Panamericana de la Salud, 2000.
30.
Telenti A, Tenover FC: “Genetic detection of antimicrobial resistance genes”. In: Bacterial Resistance to
Antimicrobials: Mechanisms, Genetics, Medical Practice and Public Health”. Lewis K, Salyers A, Taber H, Wax R.
Marcel Dekker, Inc, New York, 2001.
31.
Tenover FC, Rasheed JK: Detection and characterization of antimicrobial resistance genes in bacteria. In Manual of
29
Clinical Microbiology 8th Ed. P Murray, EJ Baron, JH Jorgensen, MA Pfaller, RH Yolken (eds). ASM Press,
Washington, D.C. 2003.
32.
Tenover FC: Bacterial strain typing through the decades: a personal reflection. In Molecular Microbiology:
Diagnostic Principles and Practices. D Persing, FC Tenover, YW Tang, D Relman, T White, J Versalovic, B Unger
(eds) ASM Press, Washington, D.C. 2003.
33.
Tenover FC, Rasheed JK: Detection of antimicrobial resistance genes and mutations associated with antimicrobial
resistance genes in microorganisms. In Molecular Microbiology: Diagnostic Principles and Practices. D Persing, FC
Tenover, YW Tang, D Relman, T White, J Versalovic, B Unger (eds) ASM Press, Washington, D.C. 2003.
34.
Tenover FC: Antimicrobial susceptibility testing of bacterial agents of bioterrorism: strategies and considerations. In
Antimicrobial Resistance: A Tribute to Stuart Levy. DG White, MN Alekshun, PF McDermott (eds). ASM Press.
2005
35.
Tenover FC, Gorwitz RJ: The epidemiology of Staphylococcus infections. In Gram-Positive Pathogens, 2nd Ed. VA
Fischetti, RP Novick, JJ Ferretti, DA Portnoy, and JI Rood (eds). ASM Press. 2006. pp 526-534.
36.
Rasheed JK, Tenover FC: Detection and characterization of antimicrobial resistance genes in bacteria. In Manual of
Clinical Microbiology 9th Ed. P Murray, EJ Baron, JH Jorgensen, ML Landry, MA Pfaller (eds). ASM Press,
Washington, D.C. 2007. pp 1248-1267.
37.
McGee L, Tenover FC, Beall B, Klugman KP: Emergence, spread, and extinction of pathogenic bacterial clones. In
Evolutionary Biology of Bacterial and Fungal Pathogens. F Baquero, C Nombela, GH Cassell, and J GutierezFuentes (eds.) ASM Press, Washington, D.C. 2008. pp 185-196.
38.
Tenover FC, McGowan JE, Jr.: Antimicrobial resistance. In International Encyclopedia of Public Health. K
Heggenhougen and S Quah (eds.) Academic Press San Diego 2008. pp 211-219.
39.
Tenover FC, McGowan, JE, Jr: The epidemiology of bacterial resistance to antimicrobial agents. In Bacterial
Infection in Humans, AS Evans and PS Brachman (eds). Springer Science and Business Media, LLC , New York,
2009. pp. 91-104.
40.
Tenover FC. Antimicrobial susceptibility testing methods for bacterial pathogens. In Antimicrobial Drug
Resistance. DL Mayers (ed.) Humana Press, New York. 2009. pp. 1151-60.
41.
Tenover FC, Hindler JF. Reporting antimicrobial susceptibility testing results. In Antibiogram. Courvalin P,
LeClercq R, Rice LB (eds). ASM Press, Washington, DC. 2009. pp. 133-140.
42.
Tenover FC, Rasheed JK: Detection of antimicrobial resistance genes and mutations associated with antimicrobial
resistance genes in microorganisms. In Molecular Microbiology: Diagnostic Principles and Practices 2nd Edition.
DH Persing, FC Tenover, YW Tang, F Nolte, A van Belkum, R Hayden (eds) ASM Press, Washington, D.C. 2011.
pp. 507-524.+
43.
Rasheed JK, Tenover FC: Detection and characterization of antimicrobial resistance genes in pathogenic bacteria.
In Manual of Clinical Microbiology 10th Ed. P Murray, EJ Baron, JH Jorgensen, ML Landry, MA Pfaller (eds).
ASM Press, Washington, D.C. 2011, pp. 1239-1261.
44.
Patel JB, Tenover FC, Turnidge J, Jorgensen. Susceptibility test methods: Dilution and disk diffusion methods. In
Manual of Clinical Microbiology 10th Ed. P Murray, EJ Baron, JH Jorgensen, ML Landry, MA Pfaller (eds). ASM
Press, Washington, D.C. 2011, pp. 1122-1143.
45.
Tenover FC: Antimicrobial Susceptibility Testing Methods for Bacterial Pathogens. In Antimicrobial Drug
Resistance. Mayers, Kaye, Sobel, and Ouilette (eds.) Springert International Publishing, AG. New York. (in press)
46.
Tenover FC: Antimicrobial Susceptibility Testing. Reference Module in Biomedical Sciences, Caplan M.(ed)
Elsevier Ltd, Oxford, UK , 2015
47.
Tenover FC: The role of molecular methods in improving public health surveillance of infections caused by
antimicrobial-resistant bacteria in healthcare and community settings In Molecular Microbiology: Diagnostic
Principles and Practices 3nd Edition. DH Persing, FC Tenover, R Hayden, M Ieven, M Miller, F Nolte, YW Tang,
and A van Belkum (eds). ASM Press, Washington, D.C. (in press).
30
Books Edited
1.
DNA Probes for Infectious Diseases, FC Tenover (ed), CRC Press, Inc., Boca Raton, 1988.
2.
Clinics in Laboratory Medicine, Volume 9, Number 2, FD Schoenknecht and FC Tenover (eds), WB Saunders
Company, Philadelphia, 1989.
3.
Interpretation of Gram Stains and other Microbiologic Stains. FC Tenover and JV Hirchsmann (eds), Upjohn
Company, Kalamazoo, 1991.
4.
Diagnostic Molecular Microbiology. Principles and Applications. DH Persing, T Smith, FC Tenover, and T White
(eds). American Society for Microbiology. Washington, D.C. 1993.
5.
Manual of Clinical Microbiology, 6th Edition. P Murray, ES Baron, M Pfaller, FC Tenover, R Yolken (eds).
American Society for Microbiology, Washington, D.C. 1995.
6.
Infectious Disease Clinics of North America, Volume 11, Number 4, FC Tenover, JE McGowan, Jr. (eds) WB
Saunders Company, Philadelphia, 1997.
7.
Manual of Clinical Microbiology, 7th Edition. P Murray, ES Baron, M Pfaller, FC Tenover, R Yolken (eds).
American Society for Microbiology, Washington, D.C. 1999.
8.
Molecular Microbiology: Diagnostic Principles and Practices. DH Persing, FC Tenover, YW Tang, D Relman, T
White, J Versalovic, B Unger (eds) ASM Press, Washington, D.C. 2003.
9.
Molecular Microbiology: Diagnostic Principles and Practices. 2nd Edition. DH Persing, FC Tenover, YW Tang, F
Nolte, A van Belkum, R Hayden (eds) ASM Press, Washington, D.C. 2010.
10.
Molecular Microbiology: Diagnostic Principles and Practices. 3nd Edition. DH Persing, FC Tenover, R Hayden, M
Ieven, M Miller, F Nolte, YW Tang, and A van Belkum (eds). ASM Press, Washington, D.C. (in press).
Abstracts
1.
Tenover FC, Mayer LW, and Young FE: Physical map of the conjugal plasmid of Neisseria gonorrhoeae. ASM,
New Orleans, LA, 1979.
2.
Graves JF, Biswas GD, Tenover FC, and Sparling PF: Transformation of hybrid plasmids in Neisseria ASM,
Miami Beach, FL, 1980.
3.
Tenover FC and Young FE: Mobilization of hybrid plasmids of Neisseria gonorrhoeae during conjugation. ASM,
Miami Beach, FL, 1980.
4.
Tenover FC, Plorde JJ, and Tompkins LS: Molecular epidemiology of aminoglycoside resistance. ACLPS, Chapel
Hill, NC, 1981.
5.
Tenover FC, Gordon K, Tompkins LS, and Plorde JJ: Use of cloned AAC(6')-II gene as a probe for aminoglycoside
resistance by colony hybridization. ICAAC, Chicago, IL, 1981.
6.
Tenover FC, Williams S, Gordon K, and Plorde JJ: Use of plasmid fingerprinting and auxotyping for
epidemiological investigations of Campylobacter jejuni. ACLPS, Rochester, NY, 1983.
7.
Totten PA, Fennell C, Tenover FC, Wezenberg J, Perine P, Stamm WE, and Holmes KK: Genetic characterization
of Campylobacter-like organisms isolated from homosexual men in Seattle. Second International Workshop on
Campylobacter Infections. Brugge, Belgium, 1983.
8.
Tenover FC, Williams S, Gordon K, Coyle M, Nolan C, and Plorde JJ: Characterization of plasmid DNA from
31
isolates of Campylobacter jejuni. ICAAC, Las Vegas, NV, 1983.
9.
Gootz TD, Gordon KP, Young SA, Tenover FC, Plorde JJ, and Tompkins, LS: Comparison of three DNA
hybridization methods for detecting an aminoglycoside ANT(2") gene in clinical isolates of bacteria. ICAAC, Las
Vegas, NV, 1983.
10.
Young SA, Gootz TD, Gordon KP, Tenover FC, and Plorde JJ: Development of two DNA probes for the
aminoglycoside 3'I and 3'II phosphotransferase genes. ICAAC, Las Vegas, NV, 1983.
11.
Tenover FC, Williams S, Gordon KP, and Plorde JJ: Analysis of tetracycline resistant isolates of Campylobacter
jejuni. ASM, St. Louis, MO, 1984.
12.
Carlson LG, Tenover FC, and Plorde JJ: Specimen volume versus yield in BACTEC blood culture system. ICAAC,
Washington, DC, 1984.
13.
Lipsky BA, Plorde JJ, Tenover FC, and Brancato FP: Comparison of acridine orange and gram stained smears and
the Automicrobic system in detecting bacteriuria. ICAAC, Washington, DC, 1984.
14.
Tenover FC, and Williams S: Cloning and expression of the tetracycline resistance gene from Campylobacter jejuni
in Escherichia coli. ICAAC, Minneapolis, Minnesota, 1985.
15.
Carlson LG, Tenover FC, and Plorde JJ: Comparison of isolate yield in 5 BACTEC blood culture media. ICAAC,
Minneapolis, MN, 1985.
16.
Tenover FC, Williams S, and Plorde JJ: Conjugal transfer of plasmids between Campylobacter jejuni and
Campylobacter coli. 3rd International Campylobacter Workshop, Ottawa, Canada, 1985.
17.
Totten PA, Tenover FC, Chen KCS, Brunch K, Holmes KK, and Stamm WE: Rapid genetic grouping test for
identification of Campylobacter species. 3rd International Campylobacter Workshop, Ottawa, Canada, 1985.
18.
Tenover FC, Filpula D, Phillips KL, and Plorde JJ: Cloning and sequencing of the structural gene of the 6'-Nacetyltransferase aminoglycoside modifying enzyme. ICAAC, New York, NY, 1987.
19.
Mayer K, Tenover FC, Hopkins J, Ellan J, Opal S, Plorde JJ, and O'Brien, T: Replacement of the ANT(2") by the
AAC(6')-I gene on an endemic conjugative plasmid by structural gene transfer while retaining a similar promoter.
ICAAC, New York, NY, 1987.
20.
Flamm RK, Tenover FC, Phillips KL, and Plorde JJ: Survey of aminoglycoside resistance genes in
Enterobacteriaceae at the Seattle VA. ASM, Miami, FL, 1988.
21.
Ryan CA and Tenover FC: Studies of erythromycin resistance in Campylobacter species. ICAAC, Los Angeles,
CA, 1988.
22.
Tenover FC, Gilbert T, and O'Hara P: Nucleotide sequence of a novel kanamycin resistance gene from
Campylobacter jejuni. 5th International Workshop on Campylobacter Infections, Puerto Vallarta, Mexico, 1989.
23.
Coll P and Tenover FC: Evaluation of a rapid method for extraction of DNA from stool. 4th European Congress of
Clinical Microbiology. Nice, France, 1989.
24.
Tenover FC, Mizuki TS, and Carlson LG: Evaluation of the MicroScan Autoscan W/A for the identification of
nonfermentative gram negative bacilli. ASM, Anaheim, CA, 1990.
25.
Tenover FC: Diagnosis of mycobacterial infection using DNA probes. Spanish Society for Microbiology and
32
Infectious Disease. Madrid, Spain, 1990.
26.
Tenover FC: Rapid methods for the diagnosis of infectious diseases. 2nd Western Pacific Congress on Infectious
Disease and Chemotherapy. Bangkok, Thailand, 1990.
27.
Tenover FC, Swenson J, McDougal L, and Facklam R: Antimicrobial resistance in respiratory pathogens. 17th
International Congress of Chemotherapy, Berlin, Federal Republic of Germany, 1991.
28.
Fasching C, Slama T, Tenover FC, and L.R. Peterson: Detection of gyrA mutations in ciprofloxacin (Cip) resistant
and methicillin-resistant Staphylococcus aureus (MRSA) from three distinct geographic locations. ASM, Dallas,
1991.
29.
Tenover FC: Emerging problems in antimicrobial resistance. ASM, New Orleans, 1992.
30.
Tenover FC: Molecular typing methods. ASM, New Orleans, 1992.
31.
Tenover FC: Comparison of traditional and molecular methods for typing Staphylococcus aureus. Australian
Society for Microbiology, Sydney, 1992.
32.
Tenover FC: Detection and identification of infectious organisms using the polymerase chain reaction. Australian
Society for Microbiology, Sydney, 1992.
33.
Tenover FC, Tokars J, Paul S, Swenson J, Spitalny K, and Jarvis W: Ability of clinical laboratories to detect
resistant enterococci. ICAAC, Anaheim, CA 1992.
34.
Tenover FC: Comparison of traditional and molecular typing methods. ICAAC, Anaheim, CA 1992.
35.
Baker CN, Banerjee S, and Tenover FC: Evaluation of the Alamar colorimetric method for antimicrobial
susceptibility testing of gram-negative bacteria. ASM, Atlanta, GA, 1993.
36.
Schwartz DN, Plorde J, Schable B, Tenover FC, and Miller RM: Cluster of Leptotrichia buccalis cases in a marrow
transplant unit: use of pulsed-field gel and fatty acid analysis to exclude common infection source. Infectious
Disease Society of America, New Orleans, LA, 1993.
37.
Tenover FC, Huang MB, Rasheed JK, Persing DH: Use of PCR to detect ampicillin resistant Haemophilus
influenzae directly in cerebrospinal fluid. ICAAC, New Orleans, LA, 1993.
38.
Jorgensen JH, Swenson JM, Tenover FC, Ferraro MJ, Hindler JA, and Murray PR: Development of interpretive
criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of
Streptococcus pneumoniae. ICAAC, New Orleans, LA, 1993.
39.
Arnold KE, Leggiadro RJ, Appleton MA, Hill B, Davis Y, Bringle D, and Tenover FC: High prevalence of
penicillin- and cefotaxime-resistant pneumococci. ICAAC, New Orleans, LA, 1993.
40.
Leggiadro RJ, Barrett FF, Chesney PJ, Davis Y, Tenover FC: Invasive pneumococci with high-level penicillin
resistance at a children's hospital. Society for Hospital Epidemiology of America, Chicago, IL, 1993.
41.
Tenover FC, Stocker SA, Baker CN: Evaluation of the bioMerieux/ Vitek Expert system. 13 e Reunion
Interdisciplinaire de Chemotherapie Anti-Infectieuse, Paris, France, 1993.
42.
Perri MB, Zervos MJ, Ferraro MJ, Tenover F, Doern G, Jorgensen JH: Multicenter comparative evaluation of a
chromogenic cephalosporin test versus cefinase disks for detection of beta-lactamase in clinical isolates. ASM, Las
Vegas, 1994.
33
43.
Tenover FC, Swenson JM, O'Hara CM, Stocker SA: Ability of 14 antimicrobial susceptibility testing systems to
detect vancomycin resistant enterococci. ICAAC, Orlando, Fl 1994
44.
Sader HS, Tenover FC, Pfaller MA, Hollis RJ, Erwin ME, Clark NC, Jones RN: Molecular typing and antimicrobial
susceptibility testing of vancomycin resistant strains from 22 US medical centers. ICAAC, Orlando, Fl 1994
45.
Jay C, Metchock B, Berkowitz F, Hill B, Tenover FC: Characterization of Escherichia coli blood isolates with
increasing resistance to ceftazidime. ICAAC, Orlando, FL 1994.
46.
Nolte FS, Metchock B, Williams T, Diem L, Bressler A, Tenover FC: Detection of penicillin-resistant Streptococcus
pneumoniae with commercially available broth microdilution panels. ICAAC, Orlando, FL 1994.
47.
Jorgensen JH, Barry AL, Ferraro MJ, Murray PR, Reller LB, Swenson J, Tenover FC: Development of additional
quality control and interpretive criteria for susceptibility testing of Streptococcus pneumoniae by NCCLS. ICAAC,
Orlando, FL 1994.
48.
Monnet D, Gaynes R, Tenover F, McGowan J, I-CARE Pilot hospitals: Ceftazidime-resistant Pseudomonas
aeruginosa (PA) and ceftazidime usage in NNIS hospitals: preliminary results of project I-CARE phase One. SHEA,
San Diego, CA 1995.
49.
Olsvik B, Tenover FC, Olsen I, Rasheed JK: Three different tet(M) subtypes identified in periodontal bacteria.
IADR, Singapore, 1995.
50.
Jacoby GA, Han P, Alvarez M, Tenover F: Survey of extendedICAAC, San Francisco, CA. 1995.
51.
d'Agata E, Venkataraman L, deGirolami P, Burke P, Eliopoulos G, Tenover F, Karchmer A, Samore M: Prospective
surveillance of ceftazidime-resistant gam negative rods (CAZ-R Gn) in surgical intensive care units (SICU).
ICAAC, San Francisco, CA 1995.
52.
McDougal LK, Rasheed JK, Tenover FC: DNA hybridization analysis of erythromycin-resistant (Emr)
Streptococcus pneumoniae variants of multiresistant 23F Spanish clone in U.S. ICAAC, San Francisco, CA 1995.
53.
Baker CN, Tenover FC: Evaluation of Alamar's colorimetric antimicrobial susceptibility test method for grampositive bacteria. ICAAC, San Francisco, CA 1995.
54.
Tenover FC, Baker CN: Development of provisional disk diffusion breakpoints for testing RP 59500
(Quinupristin/Dalfopristin): an injectable streptogramin. ICAAC, San Francisco, CA 1995.
55.
Qaiyumi S, Tenover FC, Miller M, Schawalbe RS. Evaluation of four selective media for recovery of vancomycinresistant enterococci(VRE) from fecal surveillance cultures. ASM, New Orleans, LA 1996.
56.
D’Agata E, Rasheed K, Weigel L, Venkataraman L, DeGirolami P, Samore M, Tenover F. Characterization of
ceftriaxone- resistant Enterobacteriaceae from a tertiary care hospital. American Society for Microbiology, New
Orleans, L-12, 1996.
LeBlanc DJ, Jorgensen JH, Patterson JE, Abu-al-jaibat A, Lee LN, McDougal LK, Tenover FC. 1996.
Erythromycin-resistant Streptococcus pneumoniae isolates carrying a TN917-like transposon. American Society for
Microbiology, New Orleans, A-107, 1996.
57.
58.
-lactamases in US clinical isolates.
Satake S, Rimland D, Nolte F, Clark N, Tenover FC. Surveillance of vancomycin resistant enterococci (VRE) by
using PCR. American Society for Microbiology, New Orleans, L-28. 1996.
34
59.
Rafferty ME, Baltch AL, Smith RP, Rheal C, Tenover F, Killgore G, Wilkins T, Lyerly DM, Schoonmaker D,
Hannett G, Shayegani M. Evidence for persistence of a Clostridium difficile strain over three years studied by
arbitrarily primed polymerase chain reaction (AP-PCR), protein profile (PP) and restriction enzyme analysis (REA)
typing techniques. Association of Practitioners of Infection Control. 1996.
60.
Stocker SA, Wenger JD, Tenover FC. Antimicrobial susceptibility testing of recent isolates of Neisseria
meningitidis from the United States. Interscience Conference on Antimicrobial Agents and Chemotherapy, New
Orleans, D-21. 1996.
61.
Swenson JM, Ferraro MJ, Jorgensen JH, Tenover FC. Can different breakpoints be used to detect extended-lactamase producing organisms? Interscience Conference on Antimicrobial Agents and Chemotherapy,
New Orleans, D-22 1996.
62.
Weigel LM and Tenover FC: Genetic analysis of penicillin-binding protein genes associated with carbapenem
resistance in Streptococcus pneumoniae. 97th General Meeting, ASM, Miami Beach, FL. 1997
63.
Dabney P, Bopp C, Tenover FC, Tollefson L and Angulo F: National antimicrobial monitoring system:
antimicrobial resistance in human isolates of Salmonella and Escherichia coli 0157. 97th General Meeting, ASM,
Miami, FL. 1997
64.
Hill BC, Lancaster MV, and Tenover FC: A novel disk diffusion test for detection of Penicillin resistance in
Streptococcus pneumoniae. 97th General Meeting, ASM, Miami, FL. 1997
65.
Steward C, Stocker S, Swenson JM, O’Hara JE, McGowan JE Jr, and Tenover FC: Accuracy of the agar dilution,
disk diffusion, MicroScan and Vitek systems for detection of fluoroquinolone resistance in Enterobacteriaceae. 97 th
General Meeting, ASM, Miami, FL. 1997
66.
Ostrowsky B, Gold H, Clark N, Venkataraman L, Samore M, Eliopoulos, G, Degirolam P, and Tenover FC: An
epidemiological and molecular study of VanB vancomycin-resistant enterococci at a tertiary Boston hospital. 37 th
ICAAC, Toronto, Ontario, Canada. 1997
67.
Weigel LM, Steward CD, McGowan JE Jr, and Tenover FC: gyrA mutations associated with fluoroquinolone
resistance in multiple species of Enterobacteriaceae. 37 th ICAAC, Toronto, Ontario, Canada. 1997
68.
Clark N, Teixeira LM, Facklam RR, and Tenover FC: Detection and differentiation of the vanC-1, vanC-2, and
vanC-3 glycopeptide resistance genes in enterococci. 37th ICAAC, Toronto, Ontario, Canada. 1997
69.
Swenson J, Jorgensen JH, Ferraro MJ, and Tenover FC: Activity of newer fluoroquinolones Against recent clinical
isolates of ofloxacin-resistant Streptococcus pneumoniae. 37th ICAAC, Toronto, Ontario, Canada. 1997
70.
McDougal LK and Tenover FC: Characterization of macrolide resistance phenotypes in Streptococcus pneumoniae.
37th ICAAC, Toronto, Ontario, Canada. 1997
71.
Hiramatsu K, Hanaki H, Boyle-Vavra S, Daum RS, Labischinski H and Tenover FC: Isolation and characterization
of MRSA clinical strains with reduced susceptibility to vancomycin. 37 th ICAAC, Toronto, Ontario, Canada. 1997
72.
Kellerman SE, Dembek ZF, Ganley L, Capucchione CM, Tenover FC, Cartter ML, Van Kruiningen HJ, and Jarvis
WR: Validation of vancomycin-resistant enterococci (VRE) reporting, Connecticut. 37 th ICAAC, Toronto, Ontario,
Canada. 1997
73.
Felicione EC, Steward CD, McGowan JE Jr., Tenover FC. Optimizing computer software for analysis of a
vancomycin-resistant enterococci (VRE) pulsed-field gel electrophoresis (PFGE) library. International Emerging
Infectious Disease Conference, Atlanta, GA, 1998.
35
74.
Mohammed JM, Steward CD, Tenover FC, McGowan JE Jr. Susceptibility patterns of recent isolates of
vancomycin-resistant enterococci. Abstr. C-351, p. 189. 98th General Meeting of the American Society for
Microbiology, Atlanta, GA, 1998.
75.
Hubert SK, Steward CD, TenoverFC, McGowan, JE Jr. Determination of a screening method for glycopeptideintermediate Staphylococcus aureus (GISA) and other staphylococci using Mueller-Hinton agar. 8th Annual Meeting
of Society of Healthcare Epidemiology in America, Orlando, Florida
76.
Hubert SK, Steward CD, Mohammed JM, McGowan JE Jr, and Tenover FC: Determination of a screening method
for glycopeptide-intermediate Staphylococcus aureus (GISA) and Other staphylococci using Mueller-Hinton agar
and a survey of a nationwide sample of hospitals. 98 th General Meeting, ASM, Atlanta, GA 1998.
77.
Felicione EC, Steward CD, Tenover FC, and McGowan JE Jr: Geographic region as a risk factor for clonality
among nosocomial isolates of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. 98th General
Meeting, ASM, Atlanta, GA 1998.
78.
Stosor V, Tornatore MA, Noskin GA, Tenover FC, and Peterson LR: Improved recovery of vancomycin-resistant
enterococci (VRE) using a hot-start polymerase chain reaction (PCR) assay for the detection of vanA and vanB from
rectal swabs. 98th General Meeting, ASM, Atlanta, GA 1998.
79.
Rasheed JK, Zirnstein GW, Swaminathan B, Angulo FJ, Tenover FC: Molecular characterization of ceftriaxone
resistance in two Salmonella isolates from the United States. 38th ICAAC, San Diego, CA, 1998.
80.
Weigel LM, Jorgensen JH, Ferraro MJ, Swenson JM, Tenover FC: gyrA, parC, and parE mutations associated
with pneumococcal resistance to newer fluoroquinolones. 38 th ICAAC, San Diego, CA., 1998.
81.
Dodge DE, Tang Y-W, Ellis NE, Weigel L, Tenover F, Persing DH: Phylogenetic analysis of members of the
Enterobacter cloacae group by fluorescent DNA sequencing of the 16S rRNA gene. The European Society for
Emerging Infections. Budapest, 1998.
82.
Steward CD, McGowan JE Jr, Tenover FC, Fridkin SK, Gaynes RP, Project ICARE Hospitals. Multicenter study of
susceptibility of imipenem demonstrates that testing problems persist. 36 th Annual Meeting of the Infectious
Diseases Society of America, Denver, Colorado, 1998.
83.
Tenover FC: Implications of VRSA. 4th International Meeting of the Hospital Infections Society, Edinburgh,
Scotland, 1998.
84.
Yigit H, Steward CD, Biddle JW, Tenover FC: Characterization of -lactamases and porin changes in carbapenemresistant isolates of Klebsiella pneumoniae and Serratia marcescens. 99th General Meeting, American Society for
Microbiology, Chicago, IL, 1999
85.
Steward CD, Mohammed JM, Swenson J, Tenover FC: Accuracy of six antimicrobial test systems for detecting
resistance to imipenem and meropenem in Enterobacteriaceae and Pseudomonas aeruginosa. 99th General Meeting,
American Society for Microbiology. Chicago, IL, 1999.
86.
Killgore GE, Holloway B, Tenover FC: Comparison of Conventional PCR and 5' Nuclease PCR for Detecting the
mecA Gene in Staphylococci. 99th General Meeting, American Society for Microbiology. Chicago, IL, 1999.
87.
Wallace DJ, Steward CD, Hubert SK, Lawton R, Fridkin SK, Gaynes RP, McGowan, JE, Jr., Tenover FC ,
Project ICARE Laboratories: Ability of laboratories to detect emerging antimicrobial resistance in nosocomial
pathogens. 99th General Meeting, American Society for Microbiology, Chicago, IL, 1999.
36
88.
Weigel LM, Tenover FC: Novel mutations in loci associated with fluoroquinolone resistance in Streptococcus
pneumoniae. 39th ICAAC, San Francisco, CA, 1999.
89.
Steward CD, Hubert SK, Biddle JW, Raney PM, Anderson GJ, Williams PP, Rasheed JK, McGowan, JE, Jr.,
Tenover FC: Validation of National Committee for Clinical Laboratory Standards (NCCLS) ExtendedLactamase (ESBL) Detection Method Using Clinical Isolates of Klebsiella pneumoniae. 39th ICAAC, San Francisco,
CA, 1999.
90.
Ostrowsky B, Fridkin S, Steward C, et al: . Laboratory capacity to detect emerging antimicrobial resistance. 39 th
ICAAC, San Francisco, CA, 1999.
91.
Vuopio-Varkila J, Swenson J, Killgore G, Hill B, McAllister S, Tenover FC: Evaluation of MRSA-Screen to detect
methicillin-resistant staphylococci. 39th ICAAC, San Francisco, CA, 1999.
92.
Swenson JM, Tenover FC: In vitro activity of a new cephalosporin, RWJ-54428(MC-02,479), against streptococci,
enterococci, and staphylococci, including glycopeptide-intermediate Staphylococcus aureus. 39th ICAAC, San
Francisco, CA, 1999.
93.
Thal LA, Hershberger E, Joyce K, Hill B, Marano N, Anguilo F, Gilbert L, Cobb LL, Tenover FC, Clark N,
Mackinson C, Gregg C, Debess A, Madden J, Sokolow B, Zervos MJ: Broad geographic distribution of aph(2")-Id,
a novel high level-gentamicin resistance gene in Enterococcus from humans and animals; first report in poultry from
three states. ASM, Los Angeles, CA, 2000.
94.
Daneshvar MI, Hollis DG, Steigerwalt AG, Whitney AM, Jordan JG, MacGregor JP, Hill BC, Tenover FC, Weyant
RS: Molecular characterization and antimicrobial susceptibility of CDC Group WO-2 clinical isolates. ASM, Los
Angeles, CA, 2000.
95.
Bopp CA, Puhr ND, Daniels NA, Chalk-Gaynor C, Tenover FC, Wells JG: Antimicrobial susceptibility of U.S.
isolates of Vibrio parahemolyticus determined by Etest. ASM, Los Angeles, CA, 2000.
96.
Yigit H, Anderson G, Tenover, FC: Identification of blaSVH-18 extended-spectrum beta-lactamase gene on a Tn903like transposon. ASM, Los Angeles, CA, 2000.
97.
Tenover FC, Raney PM, Williams PP, Brittain KL, Steward CD, Fridkin SK, Gaynes RP, McGowan JE, Jr.
Mechanisms of extended-spectrum cephalosporin resistance in Escherichia coli isolates from 26 United States
hospitals collected during Project ICARE. ICAAC, Toronto, Canada, 2000.
98.
Raney PM, Williams PP, McGowan JE, Jr., Tenover FC. Validation of the new Vitek version 7.01 software for
testing vancomycin against Staphylococci. ICAAC, Toronto, Canada, 2000.
99.
Murga R, McAllister S, Miller M, Tenover F, Bell M, Donlan R. Effect of vancomycin treatment of methicillinresistant S, aureus (MRSA) biofilms on central venous catheters in a model system. ASM, Orlando, 2001.
100.
Anderson G, Weigel LM, Tenover FC. Screening for mutations associated with fluoroquinolone resistance in
Streptococcus pneumoniae using double-gradient denaturing gradient gel electrophoresis. ASM, Orlando, 2001
101.
Weigel LM, Anderson GJ, Tenover FC. Analysis of parC mutations from fluoroquinolone-resistant clinical isolates
of nine species of Enterobacteriaceae. ASM, Orlando, 2001.
102.
Duck WM, Steward CD, McGowan JE Jr, Tenover FC. Comparison of molecular weight (MW) and retardation
factor (Rf) methods for software-based analysis of pulsed-field gel electrophoresis. ASM, Orlando, 2001
103.
Duck WM, Steward CD, McGowan JE Jr, Tenover FC. Optimizing matching tolerance algorithms in software
37
programs that analyze chromosomal DNA restriction patterns generated by pulsed-field gel electrophoresis. ASM,
Orlando, 2001
104.
Yigit H, Anderson GJ, Biddle JW, Steward CD, Tenover FC. Imipenem resistance in Enterobacter aerogenes is
associated with loss of a 42 kDA porin. ASM, Orlando, 2001.
105.
Weigel L, McDougal LK, Clark N, Killgore G, Tenover FC Appelbaum PC, Bozdogan B. Molecular
characterization of a vancomycin-resistant clinical isolate of Staphylococcus aureus from Pennsylvania. ASM,
Washington, D.C. 2003.
106.
Bozdogan B, Chaitram J, Appelbaum PC, Whitener C, Browne FA, Tenover FC. MICs and kill kinetics of
antibacterials against vancomycin-resistant Staphylococcus aureus with vanA gene in Hershey Medical Center.
ASM, Washington, D.C., 2003.
107.
Kuehnert M, Hill H, McQuillan G, McAllister S, Kruszon-Moran D, Fosheim G, Chaitram J, McDougal L, Jensen
B, Fridkin S, Killgore G, Tenover F. Prevalence of Staphylococcus aureus colonization in the United States – 20012002. IDSA, Boston, MA 2004.
108.
Welsh KJ, Barlow M, Tenover FC, Biddle JW, Rasheed JK, Clark LA, McGowan JE. Experimental prediction of the
evolution of ceftazidime resistance in CTX-M-2 extended spectrum beta-lactamase. ICAAC, Washington, D.C.
2004.
109.
Jevitt LA, Patel JB, McGowan JE, Jr, Tenover FC. Evaluation of FDA-approved disk diffusion breakpoint for
daptomycin. ICAAC, Washington, D.C. 2004.
110.
Carey RB, Patel JB, McAllister S., Thompson A, Raney P, Tenover FC, Ginocchio CC, Bopp D, Dumas D,
Kohlerschmidt D. Failure of automated systems to detect vancomycin resistant Staphylococcus aureus. ICAAC,
Washington, D.C. 2004.
111.
Rao A, Barlow M, Tenover FC, McGowan JE, Jr. Integrons associated with isolates of Klebsiella species and
Escherichia coli from the United States. European Congress of Clinical Microbiology and Infectious Diseases,
Copenhagen, Denmark 2005.
112.
Welsh KJ, Barlow M, Williams PP, McGowan JE JR, Tenover FC: Inability to select for high-level fluoroquinolone
resistance after in vitro mutagenesis of qnr. ASM, Atlanta, GA 2005
113.
Zhu W, Jevitt LA, Tenover FC, Patel JB. Inducible telithromycin resistance in msrA-positive Staphylococcus aureus.
ASM, Atlanta, GA 2005.
114.
McDougal LK, Patel JB, Tenover FC. Diversity of plasmid profiles among isolates of a highly stable pulsed-field
gel electrophoresis (PFGE) type of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).
ASM, Atlanta, GA 2005
115.
Aires-de-Sousa M, Boye K, de Lencastre H, Deplano A, Enright M, Friedrich A, Harmsen D, Holmes A, Huijsdens
X, Kearns A, Mellmann A, Rasheed J, Spalburg E, Strommenger B. Struelens M, Tenover F, Thomas J, Vogel U,
Westh H, Xu J, Witte W. Interlaboratory reproducibility of DNA sequencing based typing of Staphylococcus
aureus. ASM, Atlanta, GA 2005.
116.
Reik RA, Barlow M, Welsh KA, Tenover FC,
McGowan Jr, JE. Experimental Evolution of CTX-M-2 Alleles
that Confer Resistance to Piperacillin/Tazobactam, ICAAC, Washington, D.C. 2005
117.
Weigel LM, Tenover FC, Patel JB. Rapid Detection of Ciprofloxacin-Resistant B. anthracis by Microarray and
Pyrosequening Analysis. ICAAC, Washington, D.C. 2005
118.
Tenover FC, Kalsi R, Williams PP, Carey RB, Stocker S, Lonsway D, Rasheed JK, Biddle J, McGowan, Jr. JE,
Hanna B. Detection of Carbapenem Resistance in Klebsiella pneumoniae Mediated by KPC-Beta-Lactamases
ICAAC, Washington, D.C. 2005.
119.
Stone N, O’Hara CM, Williams PP, McGowan, JE, Jr., Tenover FC. Susceptibility Testing of Unusual Species of
Enterobacteriaceae: Comparison of Disk Diffusion, Vitek 2, and Broth Microdilution. ECCMID, Nice France.
38
2006.
120.
Goering RV, Larsen AR, Skov R, Tenover FC, Anderson K, Dunman PM. Comparative Genomic Analysis of
Community-Acquired ST80-SCCmec IV Staphylococcus aureus Isolates by High-Density Microarray ECCMID,
Nice France. 2006.
121.
Tenover FC, Vaughn RR, McDougal LK, Fosheim GF, McGowan, JE, Jr. Multiple locus variable number tandem
repeat assays do not differentiate between community-associated and healthcare-associated lineages of methicillinresistant Staphylococcus aureus. ECCMID, Nice France. 2006.
122.
Bonnstetter KK, Wolter DJ, Tenover FC, McDougal LK, Goering RV: Rapid Multiplex PCR Assay for
Identification of USA300 Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA)
Isolates. ASM Orlando, FL. 2006.
123.
Huang V, Tenover FC, McGowan JE, Jr. Detection of vancomycin-heteroresistant Staphylococcus aureus strains.
ASM General Meeting. Toronto, Canada, 2007.
124.
Tenover FC, Gay E, Frye S, Eells S, Healy M, McGowan, JE, Jr.: Comparison of the DiversiLab system and pulsedfield gel electrophoresis for typing methicillin-resistant Staphylococcus aureus isolates. ECCMID, Barcelona, Spain
2008.
125.
Tenover FC, Åkerlund T, Gerding D, Goering R, Eriksson T, Jonsson AM, Wong E, Wortman A, Persing DH.
Comparison of four methods of typing Clostridium difficile. 6th ClostPath International Conference on Clostridia:
The Impact of Genomics on Disease Control. Rome, Italy 2009.
126.
Tenover FC, Novak-Weekley S, Woods CW, Peterson LR, Davis T, Schreckenberger P, Fang FC, Dascal A,
Gerding DA, Nomura JH, Goering RV, Akerlund T, Weissfeld AS, Baron EJ, Wong E, Marlowe EM, Whitmore J
Persing DH: Antigen Based Assays Show Decreased Sensitivity for Several Clostridium difficile Ribotypes
Including the Epidemic 027 Strain. 5th Decennial Conference on Healthcare Associated Infections, Atlanta, GA.
2010
127.
Tenover FC, Tickler I, Persing DH, Kreiswirth B, Kubo A, Armstrong ES, Lopez S, Miller GH: Activity of
ACHN-490 Against Isolates of Methicillin-resistant Staphylococcus aureus (MRSA) from Patients in U.S.
Hospitals. ICAAC, Boston, MA. 2010
128.
Tenover FC, Tickler I, Kreiswirth B, Mediavilla J, Goering RV, Persing DH, the MRSA Consortium: Comparison
of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus (MRSA) from patients in US
hospitals. ICAAC, Boston, MA. 2010.
129.
Tickler I, Persing DH, Tenover FC: Emergence of multidrug-resistant strains of Clostridium difficile. ASM General
Meeting, New Orleans, LA. 2011.
130.
Tenover FC, Donnellan M, Tickler IA, Persing DH, Goering RV, HAI Consortium; Clostridium difficile Strain
Types from United States Hospitals. ICAAC, San Francisco, CA 2012.
131.
Tenover FC, Tickler IA, Donnellan M, Persing DH, and Goering RV: Strain types and resistance patterns of
Clostridium difficile isolates from United States Hospitals. 4th International Clostridium difficile Symposium, Bled,
Slovenia, 2012.
132.
Scharn CR, Tenover FC, Goering RV. Methicillin resistance (SCCmec) transfer in Staphylococcus aureus
populations by transduction. ASM General Meeting, Denver, CO. 2013
133.
Scharn CR, Tenover FC, Goering RV. Movement and rearrangement of Staphylococcal Chromosome Cassette mec
(SCCmec) by Transduction. IMMEM. Paris, France, 2013.
134.
Scharn CR, Tenover FC, Goering RV. Molecular characterization of staphylococcal protein A (spa) deletions in
39
clinical isolates of methicillin-susceptible staphylococcal isolates. ECCMID, Barcelona, Spain 2014
Invited Presentations
1.
"Plasmid fingerprinting for epidemiological studies of nosocomial infection." Association of Practitioners of
Infection Control, Seattle, WA, 1983.
2.
"DNA probes for infectious disease." Illinois Society for Microbiology, Chicago, IL, 1984.
3.
"Use of DNA probes for epidemiology of aminoglycoside resistance." ASM, Las Vegas, NV, 1985.
4.
"DNA probes for antimicrobial resistance genes." Workshop on Applications of DNA probes. Cold Spring Harbor
Laboratory, New York, 1986.
5.
"Plasmids and resistance factors in Campylobacter Species." Association of Official Analytical Chemists. Seattle,
WA, 1986.
6.
"Diagnostic DNA probes." California Association of Public Health Laboratory Directors. Monterey, CA, 1986.
7.
"DNA probes in clinical microbiology." South Central Association for Clinical Microbiology. Dayton, OH, 1986.
8.
"Recent advances in the detection and nomenclature of Campylobacter species." ICAAC, New Orleans, LA, 1986.
9.
"DNA probes for bacterial infections." American Medical Association "DNA Probes in Medicine." Washington,
DC, 1987.
10.
"Identification of Campylobacter spp." ASM, Atlanta, GA, 1987.
11.
"Genetics of Campylobacter species." ASM, Atlanta, GA, 1987.
12.
"DNA probes for bacterial infections." American Medical Association, "DNA Probes in the Practice of Medicine,
San Diego, CA, 1988.
13.
"Diagnosing infections with DNA probes." Riverton Hospital Continuing Medical Education Course, Riverton,
WA, 1987.
14.
"DNA probes and the clinical laboratory." Department of Pathology, University of Florida, Gainesville, FL, 1988.
15.
"DNA probes for enteric pathogens." Southern California ASM, Palm Springs, CA, 1988.
16.
"Newer methods for diagnosis of infections - use of nucleic acid probes and immunoassays." Advances in the
diagnosis of opportunistic infections of patients with immune deficiencies." ASM, Miami Beach, FL, 1988.
17.
"Cost effective use of DNA probes." ICAAC, Los Angeles, CA, 1988.
18.
"DNA probes." Northwest Medical Laboratory Symposium, Seattle, WA, 1988.
40
19.
"DNA probes for the clinical laboratory." STAMP Meeting, San Antonio, TX, 1989.
20.
"Antimicrobial resistance." Departments of Pathology and Microbiology, University of Texas at San Antonio, 1989.
21.
"DNA probes in the diagnostic laboratory - Uses and Limitations. 4th Annual Symposium on Contemporary Topics
in Clinical Microbiology and Infectious Disease. SUNY Health Science Center, Syracuse, NY, 1989.
22.
"Applications of DNA probes to the study of antimicrobial resistance." Eastern Pennsylvania Branch, ASM,
Philadelphia, PA, 1989.
23.
"Nucleic acid probes." General Principles and Techniques Workshop. Non-Cultural Methods for the Diagnosis of
Infectious Diseases. Philadelphia, PA, 1989.
24.
"Diagnostic nucleic acid probes for communicable diseases." Seminar for Latin America on Nuclear Techniques in
Parasitic and Communicable Diseases. Belo Horizonte, Brazil, 1989.
25.
"DNA probes for bacterial diseases." Third Annual Conference on DNA Probes in Medicine. San Diego, CA, 1989
26.
"Diagnostic DNA probes for infectious diseases." Fourth Annual Meeting Spanish Society for Microbiology and
Infectious Diseases. Madrid, Spain, 1990.
27.
"Molecular identification of mycobacterial infections." Fourth Annual Meeting Spanish Society for Microbiology
and Infectious Diseases. Madrid, Spain, 1990.
28.
"Diagnostic DNA probes." 2nd Western Pacific Congress on Infectious Diseases and Chemotherapy, Bangkok,
Thailand, 1990
29.
"DNA probes for the detection and identification of infectious agents." Department of Pathology Seminar, Baptist
Medical Center, Jacksonville, FL. 1991.
30.
"Novel and emerging mechanisms of antimicrobial resistance." Department of Medicine, Division of Infectious
Diseases, Vanderbilt University, Nashville, TN, 1991.
31.
"Use of DNA probes and PCR for antimicrobial susceptibility testing." ASM, Dallas, TX, 1991.
32.
"Antimicrobial resistance in respiratory pathogens." International Congress on Chemotherapy, Berlin, Germany,
1991.
33.
"Update on susceptibility testing." Metropolitan Atlanta Microbiology Association, Atlanta, GA, 1991.
34.
"The use of PCR to detect bacterial drug resistance." American Medical Association Conference. Polymerase
Chain Reaction - A diagnostic tool for the 1990's. Washington, D.C., 1991.
35.
"Use of DNA probes in clinical microbiology." Current topics in Clinical Microbiology. Creighton University,
Omaha, NE, 1991.
36.
"High Tech microbiological techniques in infection control - ready to leave the ivory tower?" Nosocomial
infectious diseases and hospital epidemiology. Harvard University, Boston, MA, 1991.
41
37.
"New problems in antimicrobial resistance" Special lecture, RIVM, Bilthoven, the Netherlands, 1991.
38.
"The use of molecular methods for diagnosis of infectious diseases", Grand Rounds, Rotterdam General Hospital,
Rotterdam, the Netherlands, 1991.
39.
"Novel methods of antimicrobial susceptibility testing: Probes and PCR", ASM, Dallas, TX 1991.
40.
"Comparison of traditional and molecular methods for typing Staphylococcus aureus". Australian Society for
Microbiology, Sydney, 1992.
41.
"Detection and identification of infectious organisms using the polymerase chain reaction." Australian Society for
Microbiology, Sydney, 1992.
42.
"Novel and emerging problems in antimicrobial resistance" South Central Association for Clinical Microbiology,
Evansville, IL, 1992.
43.
"Future direction of nucleic acid amplification", ICAAC, Workshop: PCR in the Infectious Disease Laboratory,
Anaheim, CA 1992.
44.
"New challenges in antimicrobial resistance". bioMerieux Symposium, Atlanta, GA 1992.
45.
"Diagnostic DNA probes and polymerase chain reaction for diagnosis of infectious diseases." Southeastern
Association for Clinical Microbiology, Raleigh, NC 1992.
46.
"Power, promises, and pitfalls of PCR". Association of Practitioners of Infection Control, Orlando, FL 1993.
47.
"Novel and emerging problems in antimicrobial resistance". Northeast Clinical Microbiology Society, Cleveland,
OH 1993.
48.
"Future directions of PCR". 18th International Congress of Chemotherapy, Stockholm, Sweden, 1993.
49.
"Importance of the clinical microbiology laboratory and molecular methodologies in the detection of resistant
bacteria". ASM, Atlanta, GA 1993.
50.
"Molecular versus conventional methods for in vitro detection of resistance" ASM, Atlanta, GA 1993.
51.
"Applications of PCR for infectious diseases". ASM Workshop on Diagnostic Molecular Microbiology and
Therapeutics, Jackson Hole, WY, 1993.
52.
"Emerging problems in antimicrobial resistance". IDSA, New Orleans, LA, 1993.
53.
"DNA probes as epidemiologic typing tools". 3rd International Meeting on Bacteriological Epidemiologic Markers.
Cambridge, England, 1994.
54.
"Molecular methods for detecting antimicrobial resistance genes". Association for Rapid Methods and Automation
in Microbiology. Matsuyama City, Japan, 1994.
42
55.
"Bacterial strain typing". Institute for Anaerobic Bacteriology Gifu University, Gifu, Japan, 1994.
56.
"The best of times, the worst of times, the global problem of antimicrobial resistance" Dutch Society of Hospital
Pharmacists, Bossum, The Netherlands, 1994.
57.
"A new look at antimicrobial resistance" Erasmus University, Division of Pediatrics, Rotterdam, The Netherlands,
1994.
58.
"Novel problems in antimicrobial resistance" Infectious Diseases Grand Rounds, Northwestern University, Chicago,
Illinois, 1994.
59.
"Novel problems in antimicrobial resistance" ASM Branch meeting Albuquerque, NM, 1994.
60.
"Identification and susceptibility testing of enterococci". Southern California ASM, San Diego, CA, 1994.
61.
"Strain typing methods for investigations of hospital and community outbreaks of infectious diseases", CACMID,
Montreal, Quebec 1994.
62.
"Emerging problems in antimicrobial resistance" Department of Microbiology, University of Washington, Seattle,
WA 1994.
63.
"New technologies for diagnosing emerging infectious diseases". Update in clinical microbiology, Park City, Utah,
1995.
"New approaches to susceptibility testing of nosocomial pathogens" Update in clinical microbiology, Park City,
Utah, 1995.
64.
65.
"The origins and evolution of antibiotic resistance genes". American Association for the Advancement of Science.
Atlanta, GA, 1995.
66.
"The utility of molecular epidemiologic techniques for study outbreaks of infectious diseases". Emory University,
Division of Epidemiology, Atlanta, GA 1995.
67.
"New problems in antibiotic resistance" University of Lyon, Lyon France, 1995
68.
"Molecular techniques for detecting infectious diseases" Plenary Lecture, European Congress of Clinical
Microbiology and Infectious Diseases, Vienna, Austria, 1995.
69.
"Emerging problems in antimicrobial resistance" Medical Grand Rounds, Northwestern University School of
Medicine, Chicago, IL, 1995.
70.
"National perspective of antimicrobial resistance patterns" New England Branch of the American Society for
Microbiology, Boston, MA 1995.
71.
"Molecular typing methods for the clinical laboratory" Infectious Diseases Society of America, San Francisco, CA
1995.
72.
"Using PCR for antimicrobial resistance gene detection" First European Congress on Diagnostic PCR. Amsterdam,
The Netherlands, 1995.
43
73.
"Is it time for molecular diagnostics in microbiology?" Belgian Society for Clinical Pathology, Liege, Belgium,
1995.
74.
"Molecular methods in clinical microbiology" Florida Association for Clinical Microbiology, Orlando, FL 1995.
75.
"Extended spectrum Beta-lactamases" Florida Association for Clinical Microbiology, Orlando, FL 1995.
76.
"Molecular diagnostic methods: costs and clinical relevance". Northern California Branch, ASM, Concord, CA,
1995.
77.
"Emerging problems in antimicrobial resistance" Infectious Diseases Grand Rounds, Duke University, Durham, NC
1996.
78.
“Molecular methods for antimicrobial resistance” ICAAC, New Orleans, LA 1996
79.
“Emerging problems in antimicrobial resistance” Michigan Branch American Society for Microbiology, Dearborn,
MI 1996
80.
“Molecular methods for detecting antimicrobial resistance genes”. New England Association of Clinical
Microbiology and Infectious Diseases, Boston, MA 1996
81.
“Emerging resistance to antimicrobials”. National Strategy Forum, Chicago, IL 1996
82.
“Epidemiology of vancomycin resistant enterococci in the United States”. Maurice Rapin Colloquium. Provence,
France 1996.
83.
“Application of computer software to molecular strain typing studies”. ICAAC, Toronto, 1997.
84.
“New methods of bacterial strain typing for the clinical laboratory. First Congress of Pathology and Infectious
Diseases, Rosario, Argentina, 1997.
85.
“Molecular diagnostic methods for infectious diseases” First Congress of Pathology and Infectious Diseases,
Rosario, Argentina, 1997.
86.
“Antimicrobial resistance: laboratory issues”. First International Conference on Emerging Infectious Diseases,
Atlanta, GA, 1998
87.
“Glycopeptide resistance in staphylococci”. Infectious Disease Grand Rounds, Emory University, Atlanta, 1998
88.
“Detection of vancomycin-resistant enterococci”. ASM, Atlanta, GA 1998
89.
“Glycopeptide resistant staphylococci: here, there, and everywhere” ASM, Atlanta, GA 1998.
90.
“Evidence-based anti-infective therapy: how good is the evidence from the microbiology laboratory?” Infectious
Diseases Society of Georgia, White Mountain, GA 1998.
91.
“Implications of vancomycin-resistant Staphylococcus aureus”. 4th International Meeting of the Hospital Infections
44
Society, Edinburgh, Scotland, 1998.
92.
“Glycopeptide resistant staphylococci”. Eastern Pennsylvania Branch of the American Society for Microbiology,
Philadelphia, PA, 1998.
93.
“Molecular methods versus traditional methods of susceptibility testing” International Federation of Clinical
Chemistry Societies, Florence, Italy, 1999.
94.
“Glycopeptide intermediate Staphylococcus aureus: The American experience” 21st International Congress of
Chemotherapy, Birmingham, England, 1999.
95.
“Emerging antimicrobial resistance in nosocomial pathogens” Infectious Diseases Grand Rounds, Mayo Clinic,
Rochester, MN 1999.
96.
“Clinical utility of susceptibility tests, classic versus molecular methods”. XI Brazilian Congress of Infectious
Diseases, Sao Paulo, Brazil, 1999.
97.
“The molecular basis of drug resistance”. The Association for Molecular Pathology. St. Louis, MO, 1999.
98.
“The utility of quality control and proficiency testing programs” ICAAC, San Francisco, CA, 1999
99.
“A new look at antimicrobial resistance”. Gennessee Hospital Medical Grand Rounds, Rochester, NY 1999.
100.
“The epidemiology of antimicrobial resistance: an overview”. Conference on maximizing antimicrobial efficacy and
minimizing resistance. Harvard Medical School. Boston, MA, 1999.
101.
“Vancomycin-intermediate Staphylococcus aureus: an update”. 4th Decennial Conference on Healthcare Associated
Infections, Atlanta, GA, 2000.
102.
“The predictive value of mutations associated with fluoroquinolone resistance detected by DNA sequence analysis”
ASM, Los Angeles, CA 2000.
103.
“A teleological look at antimicrobial resistance: the co-evolution of microbes and microbiologists” BD Award
Lecture, ASM, Los Angeles, CA 2000.
104.
“Infection control in healthcare: moving beyond the hospital” IMBEM5, Noordwijkerhout, the Netherlands 2000.
105.
“Staphylococcal conundrums: vancomycin and oxacillin” ICAAC, Toronto, Canada 2000.
106.
“Antimicrobial susceptibility testing”, ASM, Orlando, 2001
107.
“Emerging staphylococcal and pneumococcal resistance: two different federal responses”. ASM, Orlando, 2001
108.
“The Fastidious Organism Working Group perspective on the susceptibility and resistance of Streptococcus
pneumoniae.” ASM, Orlando, 2001.
109.
“Susceptibility testing of Bacillus anthracis and other organisms not in the NCCLS guidelines. ICAAC, Chicago,
2001.
45
110.
“Extended Spectrum β-Lactamases”. ICAAC, San Diego, 2002.
111.
“Detecting Emerging Antimicrobial Resistance Using Molecular Methods” First Coast Infectious Diseases and
Clinical Microbiology Symposium, Amelia Island, 2003.
112.
“The Emergence of Vancomycin-Resistant Staphylococcus aureus” Network on Antimicrobial Resistance in
Staphylococcus aureus meeting (NIH-funded symposium). San Antonio, TX 2003
113.
“The Real VRSA Have Arrived” 2003 Harold C. Neu Infectious Disease Conference, San Francisco, 2003
114.
“Detection of Genes and Gene Products Important for Resistance”, ASM, Washington, D.C. 2003
115.
“Challenges to detecting bacterial resistance in the laboratory”, ICAAC, Chicago, IL. 2003
116.
“VRSA, VISA, and CA-MRSA: Staphylococcal alphabet soup” IDSA, San Diego, CA 2003
117.
“The molecular basis of antimicrobial resistance in bacteria” Autonomous University of Barcelona Research
Colloquium” Barcelona, Spain 2003
118.
“The resurgence of antimicrobial-resistant Staphylococcus aureus strains as a threat to public health.” AFA
Consultants Meeting on Antimicrobial Resistance. Stockholm, Sweden, 2003.
119.
“Update on Vancomycin-Resistant Staphylococcus aureus, and other staphylococcal resistance issues.” Network on
Antimicrobial Resistance in Staphylococcus aureus meeting (NIH-funded symposium). Charlottesville, VA. 2004.
120.
“VISA, VRSA, and CMRSA: Issues in staphylococcal susceptibility testing” ASM, New Orleans, LA 2004.
121.
“Rogue Resistance Genes”: ASM, New Orleans, LA 2004.
122.
“Vancomycin-resistant Staphylococcus aureus”. International Symposium on Antimicrobial Resistance, Winnipeg,
Canada, 2004.
123.
“Community-associated MRSA”, International Symposium on Staphylococci and Staphylococcal Infections”,
Charleston, SC 2004
124.
“Update on in vitro testing for aerobic bacterial resistance”, ICAAC, Washington, D.C. 2004
125.
“VISA, VRSA, and CA-MRSA: Emerging problems in staphylococci”. University of Michigan, Department of
Microbiology Seminar. Ann Arbor, MI 2004
126.
“Emerging trends in antimicrobial resistance”. Michigan Infectious Disease Society, Detroit Michigan, 2005
127.
“Strain typing of bioterrorism agents – A CDC perspective” 7th International Meeting on Microbial Epidemiologic
Markers” Victoria, British Columbia, Canada, 2005
128.
“Tracking oxacillin-resistant staphylococci using PulseNet -USA” 7th International Meeting on Microbial
Epidemiologic Markers” Victoria, British Columbia, Canada, 2005
46
129.
“Staphylococcal infections in the United States: Trends and Tribulations” International Society of Cardiovascular
Infectious Diseases. Charleston, NC, 2005.
130.
“Update on susceptibility testing issues: more things to drive you crazy”. bioMérieux Symposium, Atlanta, GA
2005.
131.
“Rediscovering staphylococcal disease: the threat of community-associated MRSA. The microbiologists
perspective” . 22nd Chilean Congress of Infectious Diseases, Puerto Varas, Chile, 2005.
132.
“Challenges in antimicrobial susceptibility testing. Do we need additional tests?” 22 nd Chilean Congress of Infectious
Diseases, Puerto Varas, Chile, 2005.
133.
“Molecular Detection and Identification of Antimicrobial Resistance: Infection Control and Beyond.” IDSA, San
Francisco, CA 2005.
134.
“Emerging Laboratory Methods and Characterization of Community MRSA” Infectious Disease Grands Rounds,
Portland, OR. 2005.
135.
“New Mechanisms of Antimicrobial Resistance That Impact the Clinical Laboratory” Portland Clinical Microbiology
Society, Portland, OR 2005.
136.
“Emerging Antimicrobial Resistance: Trends and Tribulations” Medicine Grand Rounds, Providence Medical Center,
Portland, OR 2005.
137.
“New Approaches to the Molecular Epidemiology of Community-Associated MRSA”, ICAAC, Washington, D.C.
2005
138.
“New and Emerging Problems in Antimicrobial Susceptibility Testing” ICAAC, Washington, D.C., 2005.
139.
“Emerging antimicrobial resistance: How is the laboratory doing?” Australian Society for Antimicrobials, Sydney,
Australia, 2006.
140.
“Community-Associated Methicillin-Resistant Staphylococcus aureus: New Challenges”. Australian Society for
Antimicrobials, Sydney, Australia, 2006.
141.
“Community-Associated MRSA: A U.S. Perspective”, European Congress on Clinical Microbiology and Infectious
Diseases (ECCMID), Nice, France, 2006.
142.
“PVL Toxin and Antimicrobial Resistance Genes Enhance the Spread of Methicillin-Resistant Staphylococcus aureus
Strains” Spanish Society for Clinical Microbiology and Infectious Diseases. Valencia, Spain, 2006.
143.
“Epidemiology of Community-Associated Methicillin-Resistant Staphylococcus aureus” ICAAC, San Francisco,
2006
144.
“Antimicrobial Resistance in Staphylococcus aureus” (Division A lecture), ICAAC, San Francisco, CA 2006.
145.
“New Challenges in Antimicrobial Susceptibility Testing” Argentinian Society for Microbiology and Infectious
47
Diseases. Buenos Aires, Argentina 2006.
146.
“An Overview of Macrolide Resistance” Argentinian Society for Microbiology and Infectious Diseases. Buenos
Aires, Argentina 2006.
147.
“Automated Detection of Antimicrobial Resistance: Promises and Pitfalls”. Alliance for the Prudent Use of
Antibiotics, Boston, MA 2006.
148.
“CDC Update on Methicillin-Resistant Staphylococcus aureus Infections” Network on Antimicrobial Resistance in
Staphylococcus aureus. Reston, VA 2007.
149.
“Community-Associated MRSA: An Update from the U.S. Perspective” ASM, Orlando, FL. 2006.
150.
“Laboratory Detection of Antimicrobial Resistance: Promises and Pitfalls”. American Society for Microbiology
Northwest Branch Meeting. Seattle, WA 2007.
151.
“The Challenges of Emerging Antimicrobial Resistance”. Cambridge Health Biosciences Institute, San Diego, CA
2007.
152.
“The Evolution of Methicillin-Resistant Staphylococcus aureus” Harold Neu Infectious Diseases Conference.
Chicago, IL 2007.
153.
“Challenges in Laboratory Detection of Emerging Resistance” Wadsworth Center, New York State Health
Department, Albany, NY 2007.
154.
“Antimicrobial Resistance Among the Acinetobacters: Mechanisms and Clinical Relevance. ASM General Meeting,
Toronto, Canada. 2007.
155.
“Epidemiology and Laboratory Detection of MRSA with Reduced Susceptibility to Vancomycin” ASM, Toronto,
Canada. 2007.
156.
“Community-Associated MRSA”. 8th Colombian Congress on infectious Diseases. Bogota, Colombia, 2007.
157.
“Laboratory Detection of Emerging Resistance – 2007” 8th Colombian Congress on infectious Diseases. Bogota,
Colombia, 2007.
158.
“Emerging Resistance in Gram Positive Infections”. 8 th Colombian Congress on infectious Diseases. Bogota,
Colombia, 2007.
159.
“Multiresistant Acinetobacters and Vancomycin Heteroresistant Staphylococcus aureus: Contrasting Two Emerging
Pathogens.” Australasian Society for Infectious Diseases, Nelson, New Zealand, 2007.
160.
“Update on Antimicrobial Susceptibility Testing – 2007” ICAAC, Chicago, IL 2007.
161.
“The Epidemiology of Community-Associated MRSA Infections” ICAAC, Chicago, IL 2007.
162.
“Rapid Diagnosis of MRSA Colonization: State of the Art”. IDSA, San Diego, CA 2007.
48
163.
“Emerging Antimicrobial Resistance Issues for the Clinical Laboratory”. American Society of Clinical Laboratory
Science. Tucson, AZ, 2007.
164.
“The Challenge of Antimicrobial Resistance in 2007: Distinguishing Paradigm Drifts from Paradigm Shifts”.
Infectious Disease Association of California, Orange County, CA 2007
165.
“Changing Paradigms in Antimicrobial Resistance”. Emory University Infectious Disease Grand Rounds, Atlanta,
GA 2008.
166.
“The Epidemiology and Evolution of Community Associate MRSA”. Erasmus University, Division of Medical
Microbiology and Infectious Diseases, Rotterdam, The Netherlands, 2008.
167.
“Collaborating on global epidemics and outbreak investigations”. ASM Conference on Emerging Technologies of
Medical Importance for the Diagnosis of Infectious Diseases and the Detection of Pathogenic Microbes. Beijing.
China, 2008.
168.
“Community MRSA: Hypervirulent or just hype”. European Congress on Clinical Microbiology and Infectious
Diseases (ECCMID), Barcelona, Spain, 2008.
169.
“Update on Antimicrobial Susceptibility Testing – 2008” ICAAC/IDSA, Washington, DC, 2008.
170.
“Infection control from a microbial point of view” Georgia Infection Prevention Society, Savannah, GA 2008
171.
“Are hospital and community MRSA really different?” Federation of Infection Societies, Cardiff, Wales, 2008.
172.
“Infection control beyond MRSA”. Bay Area Association for Practitioners of Infection Control, Tampa Bay, 2009.
173.
“MRSA: An emerging pathogen with evolving antimicrobial resistance”. ASM Biodefense and Emerging
Infections Meeting, Baltimore, MD 2009.
174.
“Antimicrobial susceptibility testing of Staphylococcus aureus”. The Evolving MRSA Epidemic and the Response.
Honolulu, HA, 2009.
175.
“Antimicrobial susceptibility testing of Staphylococcus aureus. ECCMID, Helsinki, Finland. 2009
176.
“Rapid detection of resistant pathogens in the future”. ECCMID, Helsinki, Finland. 2009
177.
“Comparison of four typing methods for Clostridium difficile”. 6th ClostPath International Conference on Clostridia:
The Impact of Genomics on Disease Control. Rome, Italy 2009.
178.
“Emerging Problems with Clostridium difficile and Other Healthcare Associated Pathogens” St. Thomas and Guys
Hospital Seminars. London, United Kingdom, 2009.
179.
“Healthcare Associated Infections in 2009: Putting Some New “Control” in Infection Control” Medicine Grand
Rounds, Dameron Hospital, Stockton, CA. 2009.
180.
“Infection Prevention Challenges in 2009: MRSA and C. difficile… Still”. Orange County Association for
Practitioners of Infection Control. Costa Mesa, CA. 2009.
49
181.
“Supplementary Tests- When Routine Methods Are Not Enough”. ECCMID Vienna, Austria 2010
182.
“Rapid Diagnosis of MRSA, VRE, and Clostridium difficile Infections”. Medical Grand Rounds, El Camino
Hospital, San Jose, CA 2010
183.
“MRSA Screening - Challenges for the Laboratory and Infection Control” Northern California ASM. Pleasanton,
CA. 2010.
184.
“Challenges in the Development of Molecular Methods for the Detection of Bacterial Pathogens in Respiratory
Infections”. FDA-IDSA workshop on Molecular Detection of Respiratory Tract Infections. Bethesda, MD, 2010
185.
“Challenges in Antimicrobial Susceptibility Testing of Clinical and Environmental Isolates.” Institute of Medicine,
Washington, DC. 2010
186.
“Clinical Laboratory Standards Institute Breakpoints: An Overview.” Turkish Society for Microbiology and
Infectious Diseases. Istanbul, Turkey, 2010.
187.
“The Challenge of Antimicrobial Resistance for the Clinical Laboratory in 2010.” Turkish Society for Microbiology
and Infectious Diseases. Istanbul, Turkey, 2010.
188.
“MRSA: An Emerging Pathogen with Evolving Antimicrobial Resistance.” Infectious Diseases Grand Rounds,
Baptist Memorial Hospital, Jacksonville, FL, 2010.
189.
“Molecular diagnosis of tuberculosis.” Conference on the Rapid Detection of Human Pathogens. Mexico City,
Mexico, 2010.
190.
“The Challenge of Gram-Negative Resistance.” Infectious Disease Society of Washington, Seattle, WA, 2010.
191.
“Rapid detection of Clostridium difficile Infections.” Society for Rapid Diagnostics, Hong Kong, 2010.
192.
“Novel diagnostics for tuberculosis: from rhodamine to rodents” Second ASM conference on emerging
technologies, San Juan, Puerto Rico, 2011.
193.
“Clostridium difficile epidemiology, guidelines, and laboratory diagnosis - all in a state of flux.” Association for
Practioners of Infection Control and Epidemiology, Albuquerque, NM, 2011.
194.
“The role of molecular diagnostics in addressing multi-drug resistant organisms” .” Superbugs and superdrugs,
London, UK, 2011.
195.
“CLSI: strengths and weaknesses” Australian Society for Antimicrobials. Melbourne, Australia, 2011.
196.
“USA 300: Reflections on a biological success story.” Australian Society for Antimicrobials. Melbourne, Australia,
2011.
197.
“Rapid detection of resistant bacteria. ” ECCMID, Milan, Italy, 2011.
198.
“Novel diagnostics for tuberculosis: from rhodamine to rodents” 2 nd ASM Emerging Technologies Conference. San
50
Juan, Puerto Rico, 2011.
199.
“Detection of emergence resistance in gram-negative organisms.” ECCMID, London, UK, 2012.
200.
“Molecular methods for rapid detection of antimicrobial resistant organisms”. GTCBio Conference. South San
Francisco, CA 2012.
201.
“Molecular methods for rapid diagnosis and improving antimicrobial stewardship”. ASM General Meeting, San
Francisco, CA 2012.
202.
“Detection and characterization of MRSA infections” 13 th Asia Pacific Conference of Clinical Microbiology and
Infection. Beijing, China, 2012.
203.
“Translational medicine and the role of the translator” Washington University School of Medicine, St Louis, MO,
2013.
204.
“Molecular diagnostics for infectious diseases: From DNA probes to whole genome sequencing.” Australian Society
for Antimicrobials, Sydney, Australia, 2013.
205.
“Rapid detection of multidrug-resistant organisms: The challenge of carbapenemases.” Australian Society for
Antimicrobials, Sydney, Australia, 2013.
206.
“Emerging gram negative drug resistance and the role of public health.” California State Department of Public
Health. Richmond, CA. 2013.
207.
“The role of strain typing in hospital epidemiology.” Emory University, School of Public Health. Atlanta, GA 2013.
208.
“The evolution of healthcare associated pathogens: is it local, global, or both?” ASM General Meeting, Denver, CO
2013.
209.
“Rapid detection of resistant organisms.” 28th International Congress of Chemotherapy, Yokohama, Japan, 2013.
210.
“Developing an effective infection prevention team.” 28 th International Congress of Chemotherapy, Yokohama,
Japan, 2013.
211.
“Molecular diagnosis of tuberculosis” International conference on tuberculosis, Chengdu, China, 2013.
212.
“Rapid diagnostics for the 21st century”. Chinese Microbiology Society, 2013.
213.
“MRSA; Old pathogen, new challenges” MedLab Asia, Singapore, 2014
214.
“Novel molecular diagnostics”. Australian Society for Antimicrobials, Melbourne, Australia
215.
“Cost effective molecular diagnostics are here” Hong Kong International Meeting on Molecular Diagnostics, Hong
Kong, 2014.
216.
“Antimicrobial resistance: current challenges and future directions”. ECCMID, Barcelona, Spain. 2014
51
217.
“The role of molecular diagnostics in controlling healthcare associated infections”. Saudi Arabian Conference on
Healthcare Associated Infections, Riyadh, Saudi Arabia, 2014.
218.
“The role of molecular methods in controlling antimicrobial resistance” University of Dayton, Dayton, OH. 2014
219.
“Developing rapid tests for clinical trials of new pharmaceuticals” FDA-NIH Conference on Rapid Diagnostics and
Effective Clinical Trials, Bethesda, MD 2014
220.
“Rapid diagnostics for bacterial infections” Bio 2014-The Global Event for Biotechnology, San Diego, CA 2014
221.
“Molecular diagnostics for antimicrobial resistant bacteria” Chinese Association for Clinical Microbiology and
Infectious Diseases, Beijing, China 2014.
222.
“Molecular diagnostics: does on size fit all?” Intermountain States Seminar Series. Jackson Hole, WY, 2014.
223.
“Genotypic detection of antimicrobial resistant bacteria”. Stanford Pathology Grand Rounds, Palo Alto, CA. 2015.
224.
“Molecular diagnostics: can they be cost effective?” First Coast Clinical Microbiology Conference. Florida, 2015
225.
“Better tests, better care: The need for rapid diagnostics.” Congressional briefing, Washington, DC 2015.
52